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A B S T R A C T
Background
Healthcare systems internationally need to consider new models of care to cater for the increasing numbers of people with asthma.
Telehealthcare interventions are increasingly being seen by policymakers as a potential means of delivering asthma care. We defined
telehealthcare as being healthcare delivered from a distance, facilitated electronically and involving the exchange of information through
the personalised interaction between a healthcare professional using their skills and judgement and the patient providing information.
Objectives
To assess the effectiveness of telehealthcare interventions in people with asthma.
Search methods
We searched in the followingdatabases: CochraneCentral Register ofControlledTrials (CENTRAL),MEDLINE,EMBASE,CINAHL,
AMED, and PsycINFO; this was supplemented by handsearching of respiratory journals. We also searched registers of ongoing and
unpublished trials.
Selection criteria
We selected completed randomised controlled trials of telehealthcare initiatives aiming to improve asthma care.
Data collection and analysis
Two review authors independently appraised studies for inclusion and extracted data and performed meta-analyses. We analysed
dichotomous variables to produce an odds ratio (OR) and continuous variables to produce a mean difference.
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Main results
We included 21 trials in this review. The 21 included studies investigated a range of technologies aiming to support the provision of care
from a distance. These included: telephone (n = 9); video-conferencing (n = 2); Internet (n = 2); other networked communications (n
= 6); text Short Messaging Service (n = 1); or a combination of text and Internet (n = 1). Meta-analysis showed that these interventions
did not result in clinically important improvements in asthma quality of life (minimum clinically important difference = 0.5): mean
difference in Juniper’s Asthma Quality of Life Questionnaire (AQLQ) 0.08 (95% CI 0.01 to 0.16). Telehealthcare for asthma resulted
in a non-significant increase in the odds of emergency department visits over a 12-month period: OR 1.16 (95% CI 0.52 to 2.58).
There was, however, a significant reduction in hospitalisations over a 12-month period: OR 0.21 (95% CI 0.07 to 0.61), the effect
being most marked in people with more severe asthma managed predominantly in secondary care settings.
Authors’ conclusions
Telehealthcare interventions are unlikely to result in clinically relevant improvements in health outcomes in those with relatively mild
asthma, but they may have a role in those with more severe disease who are at high risk of hospital admission. Further trials evaluating
the effectiveness and cost-effectiveness of a range of telehealthcare interventions are needed.
P L A I N L A N G U A G E S U M M A R Y
Telehealthcare interventions for long-term asthma
Asthma is a common condition, affecting an estimated 300 million people worldwide. Its symptoms include cough, breathlessness,
wheeze and associated limitation in activity.
Increases in the prevalence of long-term conditions such as asthma are presenting considerable challenges to health services internationally
and traditional models of healthcare are struggling to cope. Emerging information and communication technologies (ICTs) have the
potential to ameliorate some of the challenges being posed through enabling and supporting patient care at a distance. Collectively
termed ’telehealthcare’ services, these interventions include the use of the telephone, videoconferencing, text-message (also known as
Short Message Service, SMS), instant messaging, email and the Internet to facilitate remote patient monitoring and decisions on care
by healthcare professionals.
The potential benefits of telehealthcare include greater accessibility for patients, reduced time and cost expenditure associated with
travelling, earlier detection of disease exacerbations and associated reduced risk of hospital admissions for asthma. These interventions
are, however, not without risk and it is therefore important to study the effectiveness of such telehealthcare initiatives rigorously.
We undertook a systematic review of the literature, searching for randomised controlled trials that have either been published or are in
progress, which studied the impact of telehealthcare on asthma outcomes.
Our searches identified a large body of trial evidence and also a substantial body of work in progress. This revealed that telehealthcare
initiatives are unlikely to be of benefit in improving quality of life for the majority of people with relatively mild asthma, but that these
interventions may prove useful in preventing exacerbations and hospital admissions in people with more severe asthma. We believe it
is important for more research to be done to establish the cost-effectiveness of these interventions.
B A C K G R O U N D
Description of the condition
There is no gold standard objective definition of asthma; its diag-
nosis is clinical, based on the presence of characteristic symptoms
(wheeze, breathlessness, chest tightness and nocturnal or exercise-
induced cough) and of variable airflow obstruction (BTS/SIGN
2008). The features of asthma are so heterogeneous that, in both
children and adults, it seems that what is currently termed ’asthma’
is unlikely in the future to be regarded as a single disease entity
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(Lancet 2006).
Much research is still needed to answer the following three funda-
mental questions:
1. What is asthma?
2. Who gets asthma and why?
3. Which factors predict exacerbations and treatment
response? (Lancet 2008)
The Global Initiative for Asthma (GINA), run in collaboration
with theWorld Health Organization and the U.S. National Heart
Lung and Blood Institute (NHLBI) and National Institute for
Health (NIH), estimates that 300 million people have asthma
(GINA 2003). Asthma is thus now a very common long-term
condition and there has been an increase in prevalence in recent
decades (Anderson 2007; ISAAC 2006; Pearce 2000). The highest
prevalence rates, as high as 30%, are amongst certain age groups
in economically developed English-speaking countries (Anandan
2010; Punekar 2009; Simpson 2010).However, there has also been
an increase in asthma prevalence in many economically-develop-
ing countries (ISAAC 2001; ISAAC 1998; ISAAC 2004; Marks
2001). These increases affect both children and adults.
Worldwide asthma presents substantial challenges. The high dis-
ease burden demands improvements in the development of and ac-
cess to treatments (Anandan 2009; Gupta 2003; Simpson 2010).
Patterns of help-seeking behaviour are also relevant, as delayed re-
porting is associated with greater morbidity and the need for costly
emergency care. There is also a significant indirect cost burden
associated with asthma through school and work absences.
Description of the intervention
Telehealthcare interventionsmay help to address some of the above
challenges by enabling remote delivery of patient-centred care, fa-
cilitating timely access to health advice and medications, prompt-
ing self-monitoring and medication compliance, and educating
patients on trigger avoidance (Car 2003; Car 2004a; Car 2004b;
McLean 2009a).
Terminology in this area is evolving rapidly and there is significant
overlap between expressions such as ’telehealthcare’, ’telemedicine’,
’telehealth’ and ’telenursing’ (Busey 2008; HRSA 2008; Lorentz
2008; Mahen 2006). For the purposes of this review, we have cho-
sen to describe the interventions under study as ’telehealthcare’.
This emphasises the use of remote information and communi-
cation technologies (ICTs) for supporting the active care of peo-
ple with asthma rather than, for example, inter professional com-
munication, passive information provision (as in traditional on-
line health tools) or unsupported patient self-monitoring through
technology. Another way of looking at this is that telehealthcare
concerns what is known as B2C or business-to-consumer, i.e. pro-
fessional to patient communication, rather than B2B or business-
to-business, i.e. inter professional communication, which is also
commonly referred to as ’telemedicine’.
Telehealthcare also avoids the use of professional role-based terms
such as telenursing (implying that remote care is delivered by a
nurse) or telemedicine (implying that care is delivered by a doctor).
It is thus compatible with the multidisciplinary nature of contem-
porary chronic disease management. This review therefore focuses
on studies which evaluate remote technological interventions that
are designed to improve the patient’s asthma with the help of any
of the following: doctor, nurse or allied healthcare professional,
from a distance.
’Telehealthcare’ has the following key elements, adapted from
Miller 2007:
1. information obtained from the patient, whether voice,
video, other audio, electrocardiography, oxygen saturation or
other;
2. electronic transfer of such information over a distance; and
3. personalised feedback tailored to the patient from a
healthcare professional who exercises their skills and judgement.
Interventions captured within the terms telehealthcare include
both synchronous and asynchronous (store and forward) technolo-
gies. For example, telephone and video-conferencing enable syn-
chronous consultations, whereas asynchronous communication
would, for example, include storing two weeks worth of spirome-
try results and then sending them on to a nurse who responds by
email or telephone.
How the intervention might work
Telehealthcare is a complex intervention and, as such, it is quite
difficult to specify exactly why it works or does not work, i.e. what
is/are the ’active ingredient(s)’ within the intervention (Medical
Research Council 2008). Some potential mechanisms through
which the use of telehealthcaremay enhance the quality of care and
achieve cost savings include (adapted from Finkelstein 2000a):
• providing patient education and counselling for primary
prevention and early detection of disease;
• replacing face-to-face nursing/doctor visits;
• improving adherence to medications and other treatment
regimens;
• monitoring patients’ health parameters remotely;
• enabling early detection of incipient disease exacerbation
and timely intervention for early symptom management;
• reducing unscheduled/unnecessary visits to the physician
and emergency room;
• preventing repeat hospitalisations.
These mechanisms are theorised to function both alone and to-
gether to bring about the effects of telehealthcare interventions.
However, we feel that the main task of this review is to uncover
whether or not these telehealthcare interventions work and then
they can be subsequently scrutinised - perhaps by more theory-
based studies - to elucidate how and why they work or do not
work.
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Why it is important to do this review
There are now in many parts of the world an increasing array
of electronic tools for remotely helping people with asthma and
often many are now beginning to be implemented in the absence
of an explicit evidence base (McKinstry 2009; McLean 2009a).
A recent Cochrane Review of generic teleconsultations compared
with face-to-face consultations found little evidence of clinical
benefit. There were also a lack of analysable data for assessing the
cost-effectiveness of these interventions. The authors concluded
that further research is required (Currell 2008).
Another systematic review (Mair 2000) of studies of patient sat-
isfaction with telehealthcare raised a number of important ques-
tions, these included:
• What types of consultation are suitable for remote
consulting?
• What are the effects of this mode of healthcare delivery on
the clinician-patient relationship?
• How do communication issues affect the delivery of
healthcare via telehealthcare?
• What are the possible limitations of telehealthcare in
clinical practice?
Answers to such questions are urgently needed or we risk blindly
implementing a non-proven way of working which may have a
negative effect on patients and professionals.
One commonly used argument for telehealthcare is that long-term
running costs will be lower than in conventional care because dis-
ease will be detected and treated early, preventing ensuing mor-
bidity and hospitalisations and allowing patients to be cared for in
their own home. However, the initial start-up costs of telehealth-
care may be substantial (Whitten 2002). The cost-effectiveness of
telehealthcare interventions therefore also need to be established.
In asthma, patients often have a high level of responsibility for
their own health. In some people it can also be a life-limiting and
challenging disease to manage. Telehealthcare interventions may
make this easier for patients by providing timely professionally
guided feedback on their condition. Such interventions may help
patients to identify and address triggers and to optimise their med-
ication regimens to address the fluctuations in their illness - and at
low cost. This is the ideal situation, however such results cannot
be presumed and a robust critique of the evidence base is overdue.
O B J E C T I V E S
To review the effectiveness of telehealthcare for people with
asthma.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included full reports of randomised controlled trials which
compared a telehealthcare interventionwith usual care or any other
control intervention.
Types of participants
Wewere interested in studies in children and adults with clinician-
diagnosed asthma.We included studies conducted in both primary
and secondary care settings. We focused on studies which looked
exclusively at people with asthma; people with chronic obstructive
pulmonary disease (COPD) were not included as this population
is being studied in a separate review (McLean 2009b). There were
no exclusions on the basis of age, gender, ethnicity or language
spoken.
Types of interventions
We stipulated that there needed to be a focus on the proactive use
of ICT to provide the information the health professional requires
to make their decisions and then feedback of their advice to the
patient. The study of technology needed to be central and its use
sustained. These interventions included the following.
1. Video or telephone links between patient and healthcare
professionals in real time or using store-and-forward
technologies.
2. Systems of care using Internet-based telecommunication;
these could be synchronous or asynchronous (e.g. Skype®,
messaging, email) with healthcare professionals.
3. Systems of care using both wired and wireless telemetry for
monitoring of Peak Expiratory Flow (PEF), spirometry (Forced
Expiratory Volume in 1 second (FEV1); Forced Vital Capacity
(FVC) respiratory rate, chest movement and oxygen saturations
involving feedback to the patient, which had been processed or
authorised by a healthcare professional.
4. Other systems of remote healthcare incorporating patient
self-reporting of symptoms on a questionnaire and information
exchange with a professional.
5. Complex intervention studies, if it was possible to tease out
the individual telehealthcare elements.
Professional involvement in care was considered fundamentally
important; we thus excluded the following types of interventions.
1. Remote interventions that were merely educational and so
did not include the input of a professional, e.g. electronic
information provision in an emergency waiting room. Although
this type of passive information provision was excluded,
education could have been part of a more complex interactive
intervention that might fit the inclusion criteria, e.g. if it
included feedback from a professional.
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2. Decision support which functioned without the active
input of a healthcare professional.
Types of outcome measures
Primary outcomes
Clinical endpoints:
1. Asthma quality of life as measured by the Juniper asthma
quality of life questionnaire (AQLQ).
2. Proportion of patients with one or more emergency
department attendances for asthma over three and 12 months.
3. Proportion of patients with one or more hospitalisations for
asthma over three and 12 months.
Other primary outcomes:
1. Symptom control as judged by use of a variety of
instruments.
2. Facilitation of access to care and overcoming barriers to care
and how this is achieved.
3. Adverse events.
Secondary outcomes
1. Study withdrawal.
2. Time off school or work.
3. PEF monitoring and diary monitoring.
4. Spirometry (FEV1, FVC).
5. Patient satisfaction.
6. Costs from the perspective of healthcare providers.
Search methods for identification of studies
Electronic searches
We identified trials using theCochrane Airways Group Specialised
Register of trials, which is derived from systematic searches of
bibliographic databases including the Cochrane Central Regis-
ter of Controlled Trials (CENTRAL), MEDLINE, EMBASE,
CINAHL, AMED and PsycINFO, and this was supplemented by
handsearching of respiratory journals andmeeting abstracts (please
see the Airways Group Module for further details. The search was
from the database’s inception, i.e. 1990 to January 2010). All
records in the Specialised Register coded as ’asthma’ were searched
using the following terms:
telehealth* or tele-health* or telemedicine* or tele-medicine* or
internet* or computer* or web* or interactive* or telecommunica-
tion* or telephone or phone or SMS or tele-monitor* or telemon-
itor* or telemanagement or tele-management or teleconsultation
or tele-consultation or telecare* or tele-care* or telematic* or tele-
pharmacy or tele-pharmacy or telenurs* or tele-nurs* or video or
email or e-mail or “remote consult*” or wireless or bluetooth or
tele-homecare or telehomecare or “remote care” or tele-support or
telesupport or “mobile healthcare” or “computer mediated ther-
apy” or ehealth or e-health or mhealth or m-health
Searching other resources
In an attempt to uncover additional relevant published data, grey
literature, unpublished data and research in progress we:
• contacted authors of the identified articles and asked them
to identify other published and unpublished randomised
controlled trials (see Table 1);
• searched the references of all included articles for further
randomised controlled trials;
• searched the UK National Institute for Health Research
Register: https://portal.nihr.ac.uk/ Pages/ NRRArchive.aspx;
and
• searched web sites listing ongoing trials: http://
clinicaltrials.gov/; http://www.controlled-trials.com/ and http://
www.actr.org.au/ (see Characteristics of ongoing studies).
Data collection and analysis
Selection of studies
The search strategy above was implemented by SM and DC
with support from Liz Arnold (Trials Search Co-ordinator in
the Cochrane Airways Group). We imported identified references
into Endnote and deleted duplicates. SM and DC independently
checked the titles and abstracts of potentially eligible studies. We
obtained full-text copies of potentially relevant studies and SM
and DC assessed their eligibility for inclusion against the criteria
outlined above. Disagreements were resolved through discussion
betweenSMandDCor in the case of agreement not being reached,
AS arbitrated. We set out reasons for exclusion in Characteristics
of excluded studies. For a PRISMA diagram of study selection see
Figure 1.
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Figure 1. PRISMA flow diagram
Data extraction and management
The following data were, where available, independently extracted
from the included studies by two review authors (SM and UN).
• Country and setting
• Design
• Participants (N, mean age, age range)
• Description of intervention - system of telehealthcare being
investigated and control group management
• Outcome measures
• Quality of life
• Health care utilisation (emergency department visits,
hospitalisation)
• Symptoms
• Access - evidence of facilitated access and improved services
or barriers overcome.
• Patient satisfaction
• PEF monitoring and diary monitoring
• Spirometry FEV1 and FVC
• Cost data, from the perspective of healthcare providers
• Study withdrawal
• Adverse events
Assessment of risk of bias in included studies
The quality of each trial was assessed following the Cochrane ap-
proach using the methods detailed in section six of the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2009).
We concentrated on the following parameters to assess quality:
1. Was the allocation sequence adequately generated?
2. Was allocation adequately concealed?
3. Was knowledge of the allocated intervention adequately
prevented during the study (blinding)?
4. Were incomplete outcome data adequately addressed?
5. Are reports of the study free of suggestion of selective
outcome reporting?
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6. Was the study apparently free of other problems that could
put it at a high risk of bias?
Each parameter was given a judgement as follows:
’Yes’ - a low risk of bias, ’No’ - a high risk of bias or ’Unclear’ -
uncertain risk of bias.
Measures of treatment effect
We consider below in detail the clinical and methodological ap-
propriateness of assessing outcomes and synthesising data across
studies.
Unit of analysis issues
We calculated summary statistics for our primary outcome mea-
sures. For dichotomous variables, we calculated an odds ratio (OR)
and for continuous variableswe calculatedmeandifferences (MD).
Dealing with missing data
We used the authors’ published data. In most cases, data had been
analysed on an intention-to-treat basis. If a study did not report a
particular variable we attempted to contact authors. If data were
still unavailable we did not include the study in the meta-analysis.
Assessment of heterogeneity
We considered the clinical heterogeneity between studies, only de-
ciding to pool data if it was considered clinically meaningful to do
so. We assessed the statistical heterogeneity between studies and
the likely impact of this heterogeneity on meta-analysis using the
I2 statistic (Higgins 2009). Where this was 40% or less, we used a
fixed-effect model. If the studies were statistically heterogeneous
(I2 statistic > 40%) we investigated the potential cause of hetero-
geneity through subgroup and sensitivity analyses. In such cases,
if the heterogeneity could not be explained, we used a random-
effects model.
Assessment of reporting biases
We used funnel plots to assess possible reporting and publication
bias.
Data synthesis
We presented pooled data graphically using forest plots. In cases
where it was not appropriate or possible to quantitatively pool
data, we produced a narrative summary of findings.
Subgroup analysis and investigation of heterogeneity
We investigated the potential causes of heterogeneity using sub-
group analysis. Subgroup analysis took account of source of pa-
tients, whether a high-risk secondary care group or potentially
lower-risk primary care population with asthma, and type of in-
tervention (whether telephone, video, web or other networked or
text message (SMS)).
Sensitivity analysis
We conducted sensitivity analyses on the basis of risk of bias in
studies, excluding studies judged to be at highest risk of bias.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies; Characteristics of ongoing studies.
(See Figure 1). Our searches found 525 titles and abstracts and
following review we considered 76 to be relevant. After detailed
examination of the 76 full texts, 21 trials satisfied our inclusion
criteria. In addition, we found 14 ongoing trials that have reported
only as abstracts (see Table 2) and a further 21 trials that have yet
to report in any format. Two studies had to be translated from
Japanese and one from Italian. It was only possible to obtain partial
translations of the Japanese reports and so the information is taken
from the studies’ figures which were published largely in English.
Results of the search
See Figure 1 for details of how we selected the 21 studies that
satisfied our inclusion criteria.
Included studies
Two studies used pharmacists as the main deliverer of the tele-
healthcare intervention (Bynum 2001; Barbanel 2003) and the
rest used a combination of doctors (both general practitioners and
specialists) and nurses, including specialist nurses.
The most common model for intervention was to have an initial
face-to-face introductory session and then follow up using tele-
phone, telephone and web, web/other networked system or text
message. This approach featured in the following studies: Barbanel
2003; Clark 2007; Donald 2008a; Guendelman 2002; Jan 2007;
Ostojic 2005; Willems 2008.
Pinnock 2003 and Donald 2008a published follow-up papers
dealing with the costs and cost-effectiveness of the interventions
(Donald 2008b; Pinnock 2005). Willems 2007a, Willems 2007b
and Willems 2008 refer to only one trial of which Willems 2007a
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is a process evaluation, Willems 2007b publishes cost-effective-
ness data andWillems 2008 is the main report. Kokubu 1999 was
expanded on in Kokubu 2000 with the addition of more data and
a section on costs; however, this was hard to interpret given the
incomplete translations.
In terms of the major telecommunication devices used in the
studies, overall nine studies used the telephone (Barbanel 2003;
Chatkin 2006; Clark 2007; Donald 2008a; Gruffydd-Jones 2005;
Khan 2004; Pinnock 2003; Pinnock 2007; Vollmer 2006). Two
studies used video (Bynum 2001; Chan 2007). In Bynum 2001
videoconferencing was used to deliver education on inhaler tech-
nique and in Chan 2007 participants submitted repeated videos
for checks of their inhaler technique via modem. One study used
text messaging (Ostojic 2005). Two studies used the Internet
(Cruz-Correia 2007; Rasmussen 2005). Other networked systems
were used by six trials (de Jongste 2009; Guendelman 2002; Jan
2007; Kokubu 1999; Kokubu 2000;Willems 2008). Van derMeer
2009 used text or internet.
Excluded studies
There were a number of reasons for excluding studies. These are all
detailed in Characteristics of excluded studies. Most often studies
were excluded because they did not fulfil our definition of tele-
healthcare, i.e. there was not a two-way exchange of information
between patient and healthcare professional. If the intervention
involved only education without feedback or if feedback was only
mechanical in nature, e.g. from a peak flow meter and not involv-
ing a professional, then the study was excluded. In addition, we
excluded studies if they were found not to employ a randomised
controlled design or if they were not studying an asthma popula-
tion.
Risk of bias in included studies
Allocation
Fifteen trials used appropriate randomisation (Barbanel 2003;
Bynum 2001; Chan 2007; Clark 2007; Cruz-Correia 2007;
de Jongste 2009; Gruffydd-Jones 2005; Jan 2007; Khan 2004;
Kokubu 2000; Ostojic 2005; Pinnock 2003; Pinnock 2007; Van
der Meer 2009; Willems 2008). For the remaining studies the
methods of allocation were either unclear (Chatkin 2006; Donald
2008a; Guendelman 2002; Kokubu 1999; Vollmer 2006) or the
authors used an inappropriate method such as consecutive ran-
domisation (Rasmussen 2005). Themost commonmethod of ran-
domisation was to use a random number table, often computer-
generated; however, other acceptable methods were also used, in-
cluding tossing a coin. In most studies which included details of
concealment, sealed envelopes were used. However, some studies
appeared to use a centralised randomisation hub, but this was of-
ten unclear.
Blinding
Four studies (Barbanel 2003; Clark 2007; Donald 2008a; Khan
2004) made some attempt to blind researchers as to the group
allocation of their participants. The remainder did not and this
may have introduced bias. Guendelman 2002 used self-reporting
of outcomes to the nurse co-ordinator so that the same person
was both involved with delivering the intervention and assessing
outcomes, thus substantially increasing the risk of bias. In Pinnock
2003, where blinding was not feasible due to the pragmatic nature
of the trial, an independent researcher validated a 20% sample of
the results.
Incomplete outcome data
Several studies had high drop-out rates (Bynum 2001; Donald
2008a; Gruffydd-Jones 2005; Jan 2007, Khan 2004). In Pinnock
2007, the uptake rate and patient population dynamics were being
studied as a primary outcome measure because it was a pragmatic
phase IV implementation trial (as per Medical Research Council
2008) (see Figure 2).
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Figure 2.
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Selective reporting
Research protocols were not sought for any of the studies. There
was nonetheless some evidence of selective reporting of results. In
most studies, all outcomes specified in the methods section were
reported in the results, however there were some exceptions, for
example in Jan 2007 the data on satisfaction were not reported
and Cruz-Correia 2007 did not report quality of life data. These
last points do not seem to relate to selective reporting, but rather
other problems.
Other potential sources of bias
Variable efforts to recruit from ethnically diverse and marginalised
populations may have impacted on the external validity of the
findings. There was variable consideration of smoking. Patients
with paper diaries filled in more than one day’s entry at a single
time point thereby opening the data to recall bias. Some studies
recruited from academic centres rather than from primary care
which may limit the generalisability of findings.
Effects of interventions
Primary outcomes - clinical
Asthma quality of life
The impact of telehealthcare interventions on disease-specific
quality of life was assessed in 14 trials (Chan 2007; Clark
2007; de Jongste 2009; Donald 2008b Gruffydd-Jones 2005; Jan
2007; Khan 2004; Kokubu 2000; Pinnock 2003; Pinnock 2007;
Rasmussen 2005; Van der Meer 2009; Vollmer 2006; Willems
2008). The effect of treatment is shown in the forest plot (Figure
3).
Figure 3. Forest plot of comparison: 1 Asthma quality of life questionnaires, outcome: 1.1 AQLQ Juniper
mean scores.
Five of these studies(Clark 2007; Gruffydd-Jones 2005; Pinnock
2003; Pinnock 2007;Vollmer2006) used Juniper’s validatedMini-
AQLQ. This instrument contains 15 items which are scored from
7 (no impairment) to 1 (maximum impairment), so high scores
indicate better quality of life. Three studies (Rasmussen 2005; Van
der Meer 2009; Willems 2008) used Juniper’s validated full 32-
item Adult-AQLQ in which similarly high scores indicate bet-
ter quality of life. Two studies used Juniper’s validated 23-item
Paediatric Asthma Quality of Life Questionnaire (PAQLQ)(Chan
2007; Willems 2008), high scores again indicate better quality of
life. Jan 2007 used the Paediatric Asthma Caregiver’s Quality of
Life Questionnaire (PACQLQ), which is filled in by the patients’
parents as did de Jongste 2009 and Khan 2004. There are 13
items in this instrument and in keepingwith the other instruments
higher scores represent better quality of life and less impairment
by asthma (Juniper 1996; Juniper 1999).
As Juniper’s quality of life instruments are similarly structuredwith
each question answered on a Likert scale with a minimum value
of 1 and a maximum value of 7, we considered it appropriate
to perform meta-analysis of the data derived from these instru-
ments. We performed a meta-analysis of Chan 2007; Clark 2007;
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de Jongste 2009; Gruffydd-Jones 2005; Pinnock 2003; Pinnock
2007; Van der Meer 2009; Vollmer 2006 andWillems 2008. This
meta-analysis of nine studies, yielding a total of 1566 interven-
tion and 1553 control patients, revealed a mean difference of 0.08
point improvement on this scale (95% CI 0.01 to 0.16) in those
randomised to intervention compared with controls (see Figure
3). This is lower than the minimal clinically important difference
of 0.5 points on the Juniper scale.
It was not possible to include other studies in the meta-analysis
because:
Rasmussen 2005 had used the AQLQ, but could not be included
because the data were not normally distributed and so median
scores were supplied by the author on request. AQLQ score was
6.42 (IQR 3.62 to 7.00) in the Internet group, 6.31 (IQR 3.98
to 7.00) in the GP group and 6.17 (IQR 1.41 to 7.00) in the
specialist group.
Donald 2008b used the Modified Marks Asthma Quality of Life
Questionnaire, a validated scale in which a higher score indicated
a less detrimental impact on quality of life. A clinically important
difference was seen in the intervention group from recruitment to
12 months. There was no clinically important difference seen in
the control group in this time.
Kokubu 2000 did not use a validated instrument for the measure-
ment of quality of life. However, they showed a greater improve-
ment in the intervention group than in the control group(P =
0.04). These results, however, need to be interpreted with caution
because of the unvalidated nature of the scale and, furthermore,
the inability to determine what constituted a minimal clinically
important difference.
Jan 2007 used the Juniper’s PACQLQ, however insufficient sum-
mary statistics were reported for meta-analysis. Only the care-
givers of asthmatic children randomised to the intervention group
showed significant improvement after the study compared to be-
fore the study.
Khan 2004 used the Juniper’s validated PACQLQ. Small increases
in median score after the study were not statistically significant for
either the control (P = 0.11) or the intervention group (P = 0.6).
These data were not normally distributed and so the mean was
not used for comparison.
Overall, across all these quality of life studies, these results suggest
that telehealthcare does not result in clinically important improve-
ments in quality of life (see Figure 3). The mean difference (fixed-
effect) is 0.08 (95% CI 0.001 to 0.16).
Analysis 1.2 shows a sensitivity analysis (fixed-effect) of high qual-
ity studies at low risk of bias only. This gave a non clinically-sig-
nificant mean difference of 0.08 (95% CI 0.00 to 0.16).
Analysis 1.3 shows a subgroup analysis by mode of communica-
tion, i.e. telephone-based, which suggests that quality of life is not
significantly improved by this form of telehealthcare: mean differ-
ence 0.04(fixed-effect) (95% CI -0.05 to 0.12).
Analysis 1.4 shows a subgroup analysis by recruitment origin in
secondary care. Again, there is no clinically important improve-
ment in quality of life with the use of telehealthcare: non-signifi-
cant mean difference (fixed-effect) 0.11 (95% CI -0.08 to 0.30).
Analysis 1.5 is a parallel subgroup analysis by recruitment origin in
primary care; again there is no significant improvement in quality
of life: a fixed-effect analysis give a mean difference of 0.11 units
(95% CI 0.02 to 0.21).
We found no evidence of publication bias (see funnel plot in Figure
4).
11Telehealthcare for asthma (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Figure 4. Funnel plot of comparison: 1 Asthma quality of life questionnaires, outcome: 1.1 AQLQ Juniper
mean scores.
Emergency department visits
Ten studies reported data on emergency department visits (Chan
2007; Clark 2007; Donald 2008a; Guendelman 2002; Khan
2004; Kokubu 2000; Pinnock 2003; Rasmussen 2005; Vollmer
2006; Willems 2008).
The effect of telehealthcare interventions on emergency depart-
ment visits over 12 months is shown in Figure 5. This meta-analy-
sis included five trials (Chan 2007; Donald 2008a; Kokubu 2000;
Rasmussen 2005; Willems 2008) representing 619 patients in to-
tal. It revealed a non-significant increase in the odds of emergency
department attendance: OR 1.16 (95% CI 0.52 to 2.58).
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Figure 5. Forest plot of comparison: 2 One or more emergency dept visit in 12 months, outcome: 2.2
Emergency department in 12 months.
In Kokubu 2000, the authors reported a greater reduction of night
and daytime emergency room visits per patient in the control
group than in the intervention group. It appears from their data
that all patients in both arms were admitted to the emergency
department at least once at some point during the study; it was
therefore not possible to include these data in the meta-analysis.
The absolute numbers of visits (presumably more often than one
per patient) are not given in the study’s English tables.
Of the other studies not included in themeta-analysis, Khan 2004
reported emergency department visits over a six-month interval
and so could not be included in the meta-analysis, but again num-
bers were very small with only one or two patients attending from
each arm over the study period. Clark 2007 reported only within-
group analyses. There were no emergency department consulta-
tions in Pinnock 2003. Vollmer 2006 did not distinguish between
emergency department care and full hospitalisation, therefore it
was not possible to include these results in the meta-analysis.
de Jongste 2009 reported survival analysis by means of a Kaplan-
Meier curve of time to first prednisolone course, emergency visit
or hospitalisation or to whichever came first. There were a total of
31 events in these categories, but the detailed breakdown of data
was not reported and so the data could not be included in meta-
analysis. However, the time to the first emergency department visit
was considered comparable across the two arms of the study (P =
0.13).
The remaining trials (Barbanel 2003; Bynum 2001; Chatkin
2006; Cruz-Correia 2007; Donald 2008b; Gruffydd-Jones 2005;
Kokubu 1999; Jan 2007; Ostojic 2005; Pinnock 2007; Van der
Meer 2009) did not include data on emergency department visits.
We produced a funnel plot (see Figure 6) for the studies which
contained data on emergency department visits over 12 months.
It is difficult to determine reliably whether publication bias was
an issue as the plot only included data from five studies.
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Figure 6. Funnel plot of comparison: 2 One or more emergency dept visit in 12 months, outcome: 2.2
Emergency department in 12 months.
Analysis 2.3 and Analysis 2.4 show emergency department visits
over 12 months separated according to the origin of their patients,
whether from primary or secondary care. Willems 2008 is not
included because patients in this study had a mix of origins. Note
the very wide confidence intervals in these data, which is a function
of there being very few events in these studies.
Hospitalisations
Six studies (Chan 2007; Donald 2008b; Guendelman 2002;
Kokubu 2000; Ostojic 2005; Rasmussen 2005) presented data
on hospitalisations. For two studies (Guendelman 2002; Ostojic
2005) these hospitalisations occurred over a three-month period.
For the remaining four studies the hospitalisations were recorded
as occurring over a 12-month period (Chan 2007; Donald 2008b;
Kokubu 2000; Rasmussen 2005).
Meta-analysis of the two studies (Guendelman 2002; Ostojic
2005) that reported data from hospitalisations over three months
of study duration is shown in the forest plot in Figure 7. This
includes data from 138 patients. Overall, there was no significant
difference in the odds of hospitalisation in the intervention groups
when compared to the control group (OR 0.47, 95% CI 0.010 to
36.46). The confidence intervals were very wide. The funnel plot
of these data (Figure 8) shows no evidence of publication bias.
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Figure 7. Forest plot of comparison: 1 Hospitalisation, outcome: 1.2 Proportion hospitalised in 3 months of
study.
Figure 8. Funnel plot of comparison: 2 Proportion hospitalised in 12 months of study, outcome: 2.1
Proportion hospitalised in 3 months of study.
Meta-analysis of the four studies (Chan 2007; Donald 2008b;
Kokubu 2000; Rasmussen 2005) which reported on hospitalisa-
tion within 12 months of randomisation is shown in Figure 9.
This includes data from 499 patients. This gave an OR of 0.21
(95% CI 0.07 to 0.61) indicating that telehealthcare reduces the
risk of hospitalisation. Chan 2007, Donald 2008b and Rasmussen
2005, however, cross the line of no difference. These studies are
large and of reasonable quality. In contrast, Kokubu 2000 which
contributes a weight of 55.6%, shows a clearly beneficial effect.
This trial focused on patients with severe asthma. Patients who had
visited the night emergency department room three times or more
within a year in spite of corticosteroid therapy were selected and so
these patients were not representative of a typical asthma popula-
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tion. In the Kokubu study, 2/32 intervention patients were hospi-
talised and 11/34 of the control patients were hospitalised. Over-
all, it therefore seems as though telehealthcare interventions may
prevent hospitalisations in selected high-risk populations studied
over long timescales. Figure 10 suggests no evidence of publication
bias, although given the small number of studies it is important
to interpret this plot with caution. Analysis 3.5 repeats the meta-
analysis without the Kokubu study this time resulting in a non-
significant reduction in the risk of admission (OR 0.30, 95% CI
0.07 to 1.25). This was done as a sensitivity analysis to show how
dependent the results of the 12-month hospitalisation study had
been on one study which may have had some unknown method-
ological flaws as we only had access to a partial translation of this
trial report.
Figure 9. Forest plot of comparison: 3 Proportion hospitalised in 12 months of study, outcome: 3.2
Proportion hospitalised in 12 months of study.
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Figure 10. Funnel plot of comparison: 3 Proportion hospitalised in 12 months of study, outcome: 3.2
Proportion hospitalised in 12 months of study.
There were no hospitalisations during the period of follow up in
Pinnock 2003 or in the Khan 2004 study. Numbers of hospitali-
sations were indistinguishable from emergency department visits
in Vollmer 2006. Chatkin 2006 reported hospitalisations over the
three-month period of its trial, but it was unclear as to whether
only data for the control group were presented and so the study
was not included in the meta-analysis.
de Jongste 2009 reports survival analysis (Kaplan-Meier curves)
of time to first hospitalisation for both groups with P = 0.13 for
intention-to-treat analysis. From the curve approximately 5% of
the intervention group were hospitalised once or more and 15%
of the control group, however as these figures are rough visual
estimates they were not used in the meta-analysis.
Gruffydd-Jones 2005 did not clearly report on the number of hos-
pitalisations, referring instead to mean length of inpatient stay.
Cruz-Correia 2007 did not report on hospitalisation as an out-
come. Jan 2007 and Pinnock 2007 did not report on hospitalisa-
tions.
Overall, hospitalisation was an infrequent outcome. In the for-
est plot for hospitalisations in studies over a three-month pe-
riod(Figure 7) it can be seen that telehealthcare is not associated
with a reduction in hospital admissions. However, there is a re-
duction over 12 months(Figure 9). This may in particular point
to a role for telehealthcare to reduce hospitalisation in high-risk
individuals. The funnel plot in Figure 10 does not show any clear
publication bias.
To test for the causes of heterogeneity according to the a priori de-
fined subgroups in the Methods section, we analysed results from
the participants originating in secondary care, then participants
originating in primary care(Analysis 3.3; Analysis 3.4).
Other primary outcomes
Symptoms
The following 17 studies reported on symptoms as an outcome
measure: Barbanel 2003; Chan 2007; Chatkin 2006; Clark 2007;
de Jongste 2009; Gruffydd-Jones 2005; Guendelman 2002; Jan
2007; Khan 2004; Kokubu 1999; Ostojic 2005; Pinnock 2003;
Pinnock 2007; Rasmussen 2005; Van der Meer 2009; Vollmer
2006; Willems 2008.
In Barbanel 2003, symptom scores improved in the intervention
group when compared to the control group over the three months
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of the study; the difference between groups at three months ad-
justed for baseline scores was 7.0 (95% CI 4.4 to 9.5, P < 0.001),
on a scale of 10 to 40. This difference remained significant when
adjustments were made for missing data.
Chan 2007 reported the number of symptom-free days recorded
by each group, but the difference between groups was not signifi-
cant (P = 0.13, our calculation).
In the Clark 2007 study, there was a small drop in the average
number of nights with night-time symptoms per month experi-
enced by the women following the intervention (from 5.1 to 3.7,
i.e. -1.4 nights). However, across groups there was no difference in
average number of nights with night-time symptoms per month:
control group 3.8 nights, intervention group 3.7 nights.
Wheezing-related sleep disturbances were studied by Chatkin
2006, but they did not use a validated questionnaire.
de Jongste 2009 calculated the within-group percentage of symp-
tom-free days. This was found to improve significantly with P
< 0.001 in both groups. The authors speculate that this may be
due to frequent monitoring and telephone contacts in both arms,
which could not be further improved by adding the nitric oxide
telemonitoring. There was no difference across groups, the base-
line-adjusted difference in mean percentage of symptom-free days
was 0.3%, (SD -10% to 11%, P = 0.95).
Guendelman 2002 reported asthma control problems between
groups as not significantly different at 12 weeks (P = 0.07).
Khan 2004 reported that there was no significant difference be-
tween groups in their primary outcome of wheezing in the last
three months.
Gruffydd-Jones 2005 reported the mean of individual changes in
the Asthma Control Questionnaire (ACQ), a validated question-
naire, over 12 months. The clinic group changed by -0.11 (-0.32
to 0.11) and the telephone group by -0.18 (0.38 to 0.02), this
representing a non-significant improvement in asthma control (P
= 0.35 when adjusted for baseline differences) (a negative change
in ACQ is an improvement).
Between group differences were significant in Jan 2007 for the
Paediatric Asthma Control Test scores change from baseline at 12
weeks: the intervention group had a significant decrease of night-
time (P = 0.028) and daytime (P = 0.009) symptoms compared
with the children in the control group. There were no between-
group comparisons in this study.
Kokubu 2000’s method for analysing the symptom score remains
obscured by the lack of a full translation of the Japanese paper.
Ostojic 2005 used a bespoke symptom score which produced sig-
nificant results across scores for the study group and control group,
demonstrating that the control group had more symptoms during
the study. Scores for cough were 1.42 (SD = 0.28) for the study
group and 1.85 (SD = 0.43), P = 0.028, and scores for sleep qual-
ity were: study group 0.85 (SD = 0.32) and control group 1.22
(SD = 0.23), P = 0.021. However, it is not reported whether this
symptom scoring system had been validated.
Pinnock 2003measured symptom scores using the ShortQ asthma
morbidity score threemonths after randomisation and found these
to be similar in the two groups. Face-to-face consultations had a
mean score of 1.96 (SD 1.96) and telephone consultations had a
mean score of 2.10 (SD 2.16), difference 0.41 (-0.41 to 0.68) (P
= 0.62), i.e. a non-significant difference.
Pinnock 2007 used the validatedACQand found anon-significant
meandifference of 0.12 (-0.06 to 0.31) (P = 0.19) for the telephone
option versus face-to-face only.
Rasmussen 2005 reported an improvement in symptoms in the
Internet versus specialist groups: OR 2.64 (95% CI 1.43 to 4.88,
P = 0.002); and also in the Internet versus GP groups: OR 3.26
(95%CI 1.71 to 6.19, P < 0.001). Here the Internet group showed
the greatest likelihood of improvement over six months.
Van der Meer 2009 used the validated ACQ to compare groups.
The Internet group showed greater improvement of asthma con-
trol than did the usual care group: change from baseline -0.54
versus -0.06; adjusted difference -0.47 (CI -0.64 to -0.3) which
was just slightly smaller than a clinically relevant difference of -
0.5 (where negative change represent improvements).
Vollmer 2006 assessed several markers of symptom status in-
cluding the Asthma Therapy Assessment Questionnaire (ATAQ),
asthma impact score, self-reported health status, self-assessed sever-
ity of asthma in the past four weeks and nocturnal waking in the
past four weeks. No significant difference between the telephone
andusual care groupswere found for any of these outcomes (ATAQ
P = 0.56, asthma impact score P = 0.46, self-reported health status
P = 0.08, self-assessed severity of asthma in the past four weeks P
= 0.22 and nocturnal waking in past four weeks P = 0.84).
Willems2008 recorded the changes in asthma symptomsof cough-
ing, productionof sputumand shortness of breath/wheezing, how-
ever no statistically significant differences in improvement in any
of the symptoms were observed.
The above results suggest that symptom scores may be improved
with telehealthcare. However, in many cases there was no differ-
ence between groups. Future research should use validated scoring
systems which can then be pooled in meta-analysis to give a more
accurate picture of the extent towhich telehealthcare interventions
improve symptom scores.
Improved access
Improved access was clearly demonstrated in the Pinnock 2003
study. Of patients randomised to receive the telephone review,
74% of patients were reviewed, whereas only 48% of patients in
the surgery-only group, were reviewed. There was therefore a sig-
nificant improvement of 26% (95% CI 14% to 37%; P < 0.001).
Asthma-related morbidity at three months (in terms of acute ex-
acerbations of asthma) P = 0.68; emergency bronchodilation P =
0.97; and steroid courses for asthma P = 0.64) were not signifi-
cantly different across groups, and neither was quality of life (Ju-
niper scores P = 0.69). And so in this study access was improved
with no loss in quality and at no additional cost (see later section
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on cost).
Access in Pinnock 2007 was also improved: the proportion re-
viewed was 66.4% of patients in the telephone option group com-
pared with 53.8% in the face-to-face only group.
Chan 2007 treated the control group with an ambulatory asthma
clinical pathway with six visits scheduled over the period of 12
months after the initial visit. The intervention group had three
in-person visits at 0, 26 and 52 weeks and the rest as virtual visits
using video-conferencing technology.
In Gruffydd-Jones 2005, 35%more asthma patients received their
annual review in the telephone group than in the clinic group and
the cost of the telephone group was less.
In Vollmer 2006, there was evidence of a negative reaction to
automated computerised calling and the intervention was more
successfully delivered in the live caller arm (P < 0.001)
Adverse events
In Gruffydd-Jones 2005 study, two patients in the telephone triage
arm died. Following contact with the author it was confirmed that
these were not asthma-related deaths.
Overall, studies did not report adverse events, with the exception
of Rasmussen 2005 which found that an increase in corticosteroid
dose was likely to result in oral candidiasis or dysphonia. In this
study at follow up an increase in inhaled corticosteroids was found
in all groups, but significantly more patients in both the Internet
and specialist groups were using inhaled corticosteroids than in
the general practice group.
Secondary outcomes
Study withdrawal
See also incomplete outcome data in Characteristics of included
studies.
Barbanel 2003: lost one patient when (s)he moved away.
Bynum 2001: 49 students were randomised. Three did not attend
any visit, eight had never used a metered dose inhaler (MDI)
before and so did not meet the inclusion criteria (the study does
not explain why they were not screened out before randomisation)
and two students did not attend the follow-up visit.
Chan 2007: 127 children were assessed for eligibility: one did not
meet the inclusion criteria, five refused to participate and one was
not able to participate. The study report does not give further
details of why not. One hundred and twenty children were ran-
domised, 11 were lost to follow up, seven discontinued because
they moved and so 55 were included in the analysis for the control
group and 47 remained for analysis in the intervention group.
Chatkin 2006: 293 patients were screened for participation, four
were excluded for not fulfilling the inclusion criteria, eight for not
responding to the telephone calls and 10 for not returning their
inhaler disk to the study office. In the final analysis control group
n = 131 and intervention group n = 140.
Clark 2007: 808 women provided baseline data and mailed a con-
sent form back following the mailing of 2336 invitation letters.
Four hundred and twenty-four were randomised to the interven-
tion group and 384 to the control group. There was then attrition
of 133 participants from the intervention group and 87 partici-
pants from the control group. The reasons for this were not re-
ported.
Cruz-Correia 2007: 21 patients were included from 28 patients
assessed in the outpatient clinic. Patients were only included if they
used the Internet. Sixteen patients provided their opinions on the
monitoring instruments. Four patients did not use themonitoring
tools because of technical problems with the instruments.
de Jongste 2009: 151 children were randomised and four children
were excluded, two due to non-compliance, one because he or she
had been inappropriately included and did not have allergy and
the final child had moved abroad and was unable to transfer data.
All others completed the study.
Donald 2008a: 660 patients were assessed for eligibility, 385 could
not be contacted, 154 did not want to take part in the study 31
were excluded and 19 did not attend the first meeting. Following
randomisation there were 36 in the intervention group with 31
left at the end of the study for analysis and 35 controls, of which
29 were left in the final analysis. The study did not discuss why
participants withdrew following randomisation.
Gruffydd-Jones 2005: 97 patients were randomised to the control
group, only 82 attended their first visit and62 completed the study,
of which 28 completed all visits and 34 completed two visits only.
Ninety-seven patients were similarly randomised to the telephone
group, 90 attended their baseline visit, three patients left the area,
two patients died and 84 completed all three visits. An explanation
for the final patient was missing from the patient flow diagram.
Guendelman 2002: Reasons for withdrawing from the study in-
cludedmoving out of the area (n = 3) or life crisis (n = 4). Five fam-
ilies who dropped out were unavailable for contact by the study
authors to find out their reasons.
Jan 2007: 184 families were eligible with access to the Internet.
Five families declined to participate as they were “too busy”, “not
interested” or found it “too complex to perform the diary card”.
Fifteen participants were excluded because of either a request from
the parents or a lack of data due to Internet failure.
Khan 2004: 310 children were enrolled in this study, 266 com-
pleted the follow-up questionnaires. The reasons for non-response
were not explored although in two cases a search of the telephone
directory enabled the discovery of a new address.
Kokubu 1999:Twopatientswithdrew from the intervention group
and one from the control group, however the reasons for this are
not described.
Kokubu 2000: Five patientswithdrew from the intervention group
and four from the control group but the reasons for this are not
described in the report according to the translation we have avail-
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able.
Ostojic 2005: Patients unfamiliar with text SMS or without con-
sistent access to a cell telephone were excluded. After enrolment
no patient withdrew from the study.
Pinnock 2003: See flow diagram (Figure 11) reproduced under
licence.
Figure 11.
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Pinnock 2007: This is a phase IV implementation study and so
there is no selection of participants. It instead takes place within
the real-world situation of general practice where patients move,
die or their asthma becomes more active or becomes inactive or is
re-diagnosed as COPD or patients refuse to take part. This reflects
the real-world population. See Figure 2, reproduced under licence.
Rasmussen 2005: 300 subjects were enrolled who fulfilled the
criteria for asthma, 253 subjects completed the trial. Reasons for
the withdrawals were not given.
Van der Meer 2009 recruitment was undertaken from 37 general
practices and continued until there were 200 patients entered in
the study. Results were available for 183 patients. Twenty patients
did not complete the three-month questionnaire, eight patients
were lost to follow up and nine patients withdrew consent.
Vollmer 2006: It is difficult to assess withdrawal in this study as
it was devised to compare usual care with automated telephone
outreach and the outcome measures were taken from a represen-
tative sample. However, participation statistics were low for the
intervention arm, only 38% participated in the first round of calls,
32% in the second round and 18% in the third round. Overall
47% of the intervention group had one call and 12.1% completed
all three calls. Compared with those who did not participate in any
call, participants were more likely to be female, take more inhaled
corticosteroids and report worse asthma-specific quality of life at
baseline. Interestingly 59.9% of the live-caller arm completed at
least one call and 27.6% all three calls, suggesting that patients
preferred a live call to the automated calls.
Willems 2008: 274 patients were assessed as potentially eligible
from patient records. Eighteen did not have a house phone con-
nection and so were excluded as not meeting inclusion criteria.
One hundred and forty-seven refused to participate because of the
following reasons: no time (n = 63), not interested (n = 28), no
symptoms (n = 18), too confronting (n = 13) and other reasons (n
= 25). Therefore, 109 were enrolled, seven were lost to follow up,
six refused participation continuation and one person emigrated.
Time off school or work
Clark 2007 reported the yearly average number of days missed
work per month as 3.0 (SD = 7.1) for the control group and 2.3
(SD = 6.2) for the intervention group (P = 0.14).
In the Donald 2008a trial, 24 intervention group participants
worked or studied and lost 10 days over 12 months, and 25 of the
control group participants lost a total of 11 days; the difference
between the groups was not significant (P = 0.58).
In Guendelman 2002, the odds of missing school in the past six
weeks in theHealth Buddy group were 0.74 (95%CI 0.37 to 1.5).
In summary, it appears that these telehealthcare interventions did
not reduce time off work or school.
PEF monitoring and diary monitoring
Chan 2007; Jan 2007; Willems 2008; Ostojic 2005 report PEF
flow monitoring.
The initial improvements in inhaler technique seen in both arms
of Chan 2007 can be attributed to the monitoring of participants
by healthcare professionals. As monitoring by the health profes-
sionals dropped in the second 26 weeks of the study to a telephone
call once a week in the control group, the participants’ inhaler
technique scores dropped off. Mean peak flow (+/-SD) as a per-
centage of personal best was reported as 91.6% (+/- 27.2) in the
intervention group and 100% (+/-17.6) in the control group at
the end of the study.
Monitoring, or more accurately “prompting”, was also important
in Chatkin 2006, a study in Brazil. A twice-weekly telephone call
made by a trained student nurse to the patients in the experimental
arm resulted in an inhaler adherence rate of 74.3 % whereas the
rate in the control arm was only 51.9% (number needed to treat
to benefit 4.5, i.e. telephone calls to 4.5 patients were required to
prevent one non-adherence or missed inhaler dose). The content
of the telephone call was individualised to each patient.
In keeping with this advantage of monitoring, Kokubu 1999 also
found that those patients who checked their peak flow most reg-
ularly tended to have the best peak flows. Patients who did not
check or transmit peak flow data regularly remained poorly con-
trolled.
In Jan 2007, at week 12, children in both groups had a significantly
increased PEF. Between-group differences are reported as non-
significant.
Willems 2008 reports rank correlations of lung function values
(PEF and FEV1) with morning symptoms and evening symptoms
as moderate to high. Absolute values were not reported in the
study.
Peak flow in L/min was measured by Ostojic 2005 as mean PEF
by time of day(morning, afternoon, evening) none of which were
significant. However, PEF variability (%) in the text message in-
tervention group (16.12 +/- 6.93) and the control group (27.24
+/- 10.01) showed a significant difference (P = 0.049).
Therefore, overall it can be seen that telehealthcare improved PEF
in some studies, but that thiswas not a consistent finding.However
monitoring in itself appeared to generate an advantage.
Spirometry FEV1/FVC
Chan 2007, de Jongste 2009, Ostojic 2005, Rasmussen 2005 and
Van der Meer 2009 reported data on FVC and FEV1 as follows.
There were no differences between groups in FVC, forced expira-
tory volume in 1 second or forced expiratory flow in mid-expira-
tory phase at the end of the Chan 2007 study.
FEV1was similar at baseline in both groups in de Jongste 2009 and
there was no significant difference in change frombaseline over the
course of the study between the groups: both groups improved.
Neither FVC nor FEV1 as a percentage of predicted was signifi-
cantly different across the groups in Ostojic 2005.
Rasmussen 2005 reported odds ratios for improved FEV1 > 300
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ml over baseline of 3.26 (1.50 to 7.11) for Internet versus specialist,
with a significance of P = 0.002. The odds ratio of Internet versus
GP group was also significant at P < 0.001(OR 4.86, 95%CI 1.97
to 11.94). These odds ratios were calculated after six months of
intervention.
Van der Meer 2009 reported that mean pre-bronchodilator FEV1
changed by 0.24 L for the Internet and -0.01 L for the usual care
group thus indicating an improvement in the telehealthcare arm’s
FEV1.
Patient satisfaction
In the Cruz-Correia 2007 study, questionnaires were used to assess
patient satisfaction and it was found that overall patients preferred
the web-based system for monitoring their asthma to the paper-
based system.
Gruffydd-Jones 2005 triaged patients in the intervention group by
telephone call then allocated follow-up appointments accordingly.
Of patients in this group 88% expressed a strong preference for
care in this form compared to the previous standard form.
Pinnock 2005a is an additional report of patients who had com-
pleted the RCT comparing telephone and face-to-face consulta-
tions for routine asthma reviews; they were sent a questionnaire
to better understand their preference for future reviews. Thirty-
three percent preferred telephone consultations for future reviews,
17% preferred surgery and 50% expressed no preference. The-
matic analysis of the free-text responses identified five themes in-
cluding convenience of telephone consultations, specific problems
with telephone consultations (e.g. confidentiality when phoning
from a public place), the human dimension of face-to-face encoun-
ters, that the mode of consultation might change according to the
clinical situation and wider implications such as using email for
attachment of PEF information. In summary, patient satisfaction
appeared to be high, but these newer approaches did not appear
to suit all patients.
In Bynum 2001 and Pinnock 2003 there was no significant dif-
ference in the satisfaction scores of each of the arms (Bynum 2001
P = 0.132 and Pinnock 2003 P = 0.51)
Kokubu 2000 asked the following satisfaction related questions:
Yes (%) No (%) Don’t know (%)
Your self
management of asthma has im-
provedwith regard tomedicines
regularly and/or coping?
74 11 13
This system is useful for control
of your asthma?
89 0 11
AirWatch measuring and/or
data transfer is a burden to you?
11 70 19
Telephone consulting by your
nurse is a burden to you?
4 92 4
Do you feel your privacy is dis-
turbed?
0 89 11
What did you think about the frequency of telephone consulting?
1. Adequate 87%
2. Too much 7%
3. Too few 3%
4. No response 3%
Data are reproduced from Kokubu 2000 with permission from
the authors.
It was therefore clear that the telehealthcare patients in the Kokubu
2000 study were overall very satisfied.
Insufficient detail was reported by Chan 2007 to interpret the
satisfaction scores published.
Willems 2007a found no clinically important differences between
a satisfaction questionnaire administered at fourmonths and again
at 12 months. Both arms of the trial used a PEFmonitor and both
arms answered the satisfaction questionnaire. Only 4% of patients
experienced “a lot” of symptoms over the previous months. Forty
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percent of patients said that they would like to use the monitor
again in the future; 36% said maybe. Ninety-four percent of pa-
tients were either much or very much appreciative that lung func-
tion deterioration is immediately noticed by the nurse. Eighty-
four percent said that they felt “not at all less safe contacting the
nurse instead of the doctor”. Eighty-seven percent found that they
had a qualitative improvement by playing an active role in their
asthma management. Sixty-five percent felt safer while using the
monitor. Eighty-four percent said the monitor did not interfere
with their daily activities. With regards to questions on the appli-
cation of the monitor both children and adults were highly satis-
fied with using the monitor, 87% finding it “not difficult at all”
to perform the spirometry test.
Costs from the healthcare perspective
This refers to the costs of providing the intervention compared
with differences in outcomes between the intervention and con-
trol groups (all currency conversions were undertaken in February
2010 to US dollars).
In Pinnock 2005 the cost to the practices of face-to-face asthma
reviews was $17.31 each per consultation achieved as there was a
higher default rate than for telephone reviews. Telephone reviews
reachedmore patients at $11.20 per consultation achieved. Access
was therefore improved at lower cost per consultation, however
overall costs were similar because more patients were interviewed
in the telephone group.
In Pinnock 2007, the cost per patient reviewed was significantly
lower in the telephone option group; $15.63 versus $19.85. This
generated a cost saving per patient reviewed of between $4.02 and
$4.41 per patient reviewed (i.e. per six-monthly review achieved).
Data on costs were published in the Donald 2008b paper. The
overall cost of delivering the intervention from the healthcare per-
spective was $1693.91, i.e. the additional six phone calls each over
the study time period for all intervention patients. These calls re-
sulted in the intervention group having six readmissions overall,
as opposed to the control group’s 20 readmissions to hospital. The
total cost of the hospital readmissions in the control group was
$35,878.52. Therefore there was a significant cost saving solely on
the basis of reduced hospital admissions. The intervention group
also showed a clinically significant increase in quality of life scores
over the 12-month follow-up period in comparison to no change
in the control group’s scores. Formal cost-effectiveness analysis
looking at Quality Adjusted Life Years (QALYs) or Disability Ad-
justed Life Years (DALYs) was not undertaken.
In the Kokubu 2000 study, it was estimated that a saving of $7074
per year per patient would be achieved if they were to use the
telehealthcare system rather than conventional treatment, these
savings largely being achieved by a reduction in hospitalisation
costs.
In Willems 2007b, costs from the societal perspective were calcu-
lated by costing from the healthcare perspective and adding the
cost of over-the-counter medication, family informal care and pro-
ductivity losses due to time off work. Cost-effectiveness data were
calculated from the costs and the quality of life data from EQ-5D
utility (adults and children) and the SF-6D utility (adults only).
Cost-effectiveness depends on what society is prepared to pay per
QALY gained. Among adults the healthcare costs were a mean of
$695.54 higher in the intervention group. After adjustment for
baseline differences by multiple regression an average 0.03 QALY
were gained from the intervention. This equates to $42,520.39
(31,035 Euros) per QALY gained from the societal perspective.
Among children the healthcare costs were $829.56 higher in the
intervention group. On average 0.01 QALY were gained from the
intervention, equating to $80,437.16 (59,071 Euros) per QALY
from the societal perspective.
Overall it therefore appears that the studies which analysed
costs found that where hospitalisation was prevented, costs were
favourable to continuing the intervention. However, this did not
hold true for all studies.
D I S C U S S I O N
Summary of main results
This review included 21 trials measuring the effects of telehealth-
care interventions. Overall, this review indicates that telehealth-
care-based interventions do not have an appreciable impact on
disease-specific quality of life or risk of emergency department
attendance for asthma; they may, however, result in a reduction
in the risk of hospitalisation for asthma, particularly in high-risk
populations.
This latter finding is consistent with the high hopes that policy-
makers hold for telehealthcare in terms of its ability to prevent
asthma patients requiring hospital admission. However, this meta-
analysis is highly reliant on the results from the Kokubu and Don-
ald studies. The Kokubu study selected a group of patients who
had very poorly controlled asthma, requiring oral steroids at least
three times in the previous 12 months or having had a previous
hospital admission, and so they were much more likely to be ad-
mitted to hospital at baseline than patients in other studies which
were based in primary care. In addition, our knowledge of this
study is incomplete due to difficulties in translating this article.
When the data were analysed without the Kokubu study the rate
of hospitalisations over 12 months became non-significant (see
Analysis 3.5; P = 0.1). Similarly, the Donald study recruited from
a group of adults who had been admitted to hospital with their
asthma at some point previously (see Analysis 3.3 - secondary care
subgroup). These two studies together suggest that telehealthcare
might be most useful for high-morbidity asthma groups selected
from secondary care over longer intervals (i.e. greater than 12
months). However, overall hospitalisations represent infrequent
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events and so generalisation from this limited number of patient
outcomes should only be undertaken cautiously.
Symptom scores data were inconsistent and often reported as
within-group changes rather than across-group changes. In some
instances telehealthcare related to improved symptoms, butmostly
the reporting of data was not robust enough to draw any clear
conclusions.
There were few adverse events. There is always a risk in reducing
the level of care from face-to-face to telehealthcare that if patients
are inexpertly triaged theywill receive insufficient support for their
needs and their safety will be compromised. We, however, found
no evidence of this having happened. This suggests that authors
were aware of this risk and managed it appropriately.
This review did identify a tendency for patients to abandon the
technology and cease self-monitoring when they felt well; for ex-
ample in Chan 2007 children’s adherence to submission of inhaler
technique videos decreased over time. This observed pattern calls
into question not only what works for asthma in telehealthcare
and in what contexts, but for whom too. It seems that many of
the primary care population with asthma do not see themselves as
having a chronic illness needing constant medication but as hav-
ing an occasional acute inconvenience - this is a separate issue that
is best explored using qualitative designs (Gallagher 2009; Mort
2008).
Overall completeness and applicability of
evidence
Nine of the 21 studies included in this review studied the tele-
phone as an intervention. However, Tulu 2007 found that only
6.6% of the telemedicine projects listed in the Telemedicine Infor-
mation Exchange survey used the “Plain Old Telephone System”
(sic). It would seem that more modern technologies such as video-
conferencing, Skype® and web 2.0 technologies are attracting in-
terest but have not yet made it into the asthma literature.
There were several trials which had a very low participation rate
for collection of their follow-up data, e.g. approximately 38% in
Vollmer 2006 and 27% in Delaronde 2005.
Studies varied in their recruitment either fromhospital outpatients
or emergency departments in which case patients with more severe
forms of asthma were recruited than in primary care where the
patients with milder asthma were recruited. The type of patient
in the study had implications for the findings as we saw with the
Kokubu and Donald studies.
There is a plethora of ongoing research and research that has as
yet only been published in abstract form. This emerging literature
includes a number of studies looking at networked telehealthcare
tools. It is worth noting that in the situations in which such solu-
tions might provemost useful, e.g. remote and rural settings, there
may be anticipated difficultieswith broadband linkage required for
networks. Similarly, frail, elderly people who could benefit from
telehealthcare to help to maintain their independence may lack
the cognitive skills to be able to adapt to network interfaces and
so have difficulties using the technology at all.
The research in this review has mostly taken place in a developed
world setting with the equivalent of primary and secondary care,
sometimes transferring the responsibility for care from secondary
to primary, or setting up a type of preventative secondary care.
As such it is likely to be broadly transferable to other developed
world settings. It is quite possible that some types of telehealthcare
may work well in the developing world as well. This is because
the developing world often has good mobile telephone network
coverage.However, the devices for interfacingwith patients require
reliable electric power and skilled labour which might be more
difficult to secure in such countries.
Quality of the evidence
In general, the biases seen included a lack of proper randomisa-
tion, problems with allocation concealment and a lack of overt
statements of specific methodological processes, such as blinding.
Therefore many of the risk of bias tables were often populated
with the judgement ’unclear’ due to insufficient information.
The decision to structure Rasmussen 2005 with three trial arms
is problematic when it comes to interpreting findings and synthe-
sising across studies.
Using “adherence” as an outcome measure infers a link which is
not yet necessarily established for telehealthcare; that improved
adherence, a process measure, will improve hard clinical endpoints
such as numbers consulting at the emergency department or pa-
tients being hospitalised. Increased use of process measure out-
comes during trials will deepen understanding of why specific in-
terventions might be successful when others are not. Process mea-
sures also help clarify how well the trial is being executed.
In other instances, data are presented in such a way that it is not
clear whether there was a clinically significant decrease in days and
nights with symptoms or time off work. Results were presented as
within-group differences over the time period and frequently sta-
tistical significance was quoted but not interpreted. For example,
see Clark 2007 where the control group’s symptoms decrease by
more than the treatment group’s.
Potential biases in the review process
The lack of full translations for the Kokubu 1999 and Kokubu
2000 papers may mean that some information is missing.
Leaving out qualitative trials may mean that some studies are ex-
cluded fromwhich useful lessons could be learnt (Shepperd 2009).
Qualitative data has an important role to play when studies deliver
complex interventions. These kinds of studies help us understand
the uptake or otherwise of telehealthcare interventions. However,
the techniques for systematically reviewing such studies are in their
infancy.
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Future updates of this review are expected to include more net-
worked and Internet-based technologies and not repeat the dom-
inance of this literature by the ordinary telephone.
Agreements and disagreements with other
studies or reviews
There are several reviews (Botsis 2008; Garcia-Lizana 2007) which
consider the evidence of studies of telemedicine, telecare and tele-
health although the inclusion criteria are variable and they are
largely concerned with chronic diseases other than asthma, in par-
ticular for elderly populations.
A review by Duvvuri 2007 focused on asthma and ICTs, espe-
cially the world wide web. Its inclusion criteria were broader than
for this Cochrane Review in that the authors searched for deci-
sion support and patient education tools as well as the technolo-
gies we would have classified under our narrower definition of
telehealthcare. Studies were summarised in narrative form and no
meta-analysis was attempted. Overall, Duvvuri was favourable to
the increasing use of telehealthcare to help manage the increas-
ing worldwide burden of asthma. They also drew attention to
some favourable cost-effectiveness and patient-satisfaction analy-
sis. In addition, they identified the remaining hurdle of physician
licensing and reimbursement when care is delivered via telehealth-
care. This is particularly an issue in countries with insurance-based
healthcare.
Whitten 2002 was a systematic review of cost-effectiveness studies
of telemedicine interventions; they highlighted that the relative
cost-benefit calculations are fundamentally affected by the context
in which the intervention is implemented. The example they gave
was that they recognised that a service which is highly cost-effec-
tive in the Highlands of Scotland is unlikely to be so in the ur-
ban environment of Manchester, England where accessibility and
quality of local services is much higher. In total, they found 55
articles with cost data and only 24 of these met the quality criteria
for inclusion in their review. Twenty out of 24 were simple cost
comparisons and there were no studies of cost utility analysis: they
concluded that this made it impossible to say which telemedicine
interventions truly represented “value for money.” The cost data
presented above for this Cochrane Review includes two cost com-
parisons and a full cost utility analysis in terms of “cost per QALY
gained” in children and adults.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
This review has found 21 randomised controlled trials researching
the effects of telehealthcare intervention for asthma. In addition,
we found 21 ongoing studies and unpublished trials. Despite some
lack of consistency in the way telehealthcare has been researched
thus far (see below), this represents a substantial body of reason-
ably high quality research in different settings internationally and
assessing different technologies. Some positive conclusions can be
drawn. Telehealthcare improves access and is no worse than nor-
mal care in carefully selected and triaged primary and secondary
care patients. It does not, however, appear to have the desired im-
pact on quality of life and these interventions have little or no sig-
nificant impact on emergency department visits. However, given
careful candidate selection conditions, telehealthcare may reduce
hospital admission rates and associated costs. There is also some
evidence for improved symptoms in telehealthcare trial armswhere
symptoms are dealt with quickly and exacerbations are prevented
in a way not open to the control arm.
Implications for research
One of the problems with telehealthcare research that we have
seen in this review is that the control arm is not always usual care,
but often receives an enhanced input from the clinicians - for ex-
ample, a greater number of visits or face-to face contacts and so
this results in greater adherence to medications and surveillance
of disease fluctuations in both arms of the trial and improved out-
comes for both arms. Telehealthcare fits into theMedical Research
Councils’s model of a “complex intervention” (Medical Research
Council 2008) and as such it seems that each telehealthcare in-
tervention is very diverse. This can make it very hard to pinpoint
the “active ingredients” of a telehealthcare intervention. Confu-
sion also comes from the different modes of delivery within the
bracket of telehealthcare. For example, both Internet- and tele-
phone-based “helplines” improve access to clinicians for patients.
In this example it is the function of improving access which leads
to reduced hospitalisations - and so far the evidence shows that
this is not to the detriment or advantage of quality of life. The
form of the intervention, whether telephone or Internet, seems to
have less of an impact than the function of the access which results
in timely advice to prevent exacerbation in a way that outpatient
clinics cannot deliver in comparison. It is important then in fu-
ture studies that interventions are described as fully as possible,
that relevant process or intermediary measures are studied, and
consideration is also given to embed qualitative work within these
complex intervention trials to help assess how these interventions
exert their effects (Shepperd 2009).
Future telehealthcare interventions studied are likely to be even
more complex and include the features of web 2.0. Such research
is important to find how best to harness these innovative technolo-
gies without inadvertently causing harm. It is, however, important
that these interventions are patient-centred, and that they are de-
veloped through close consultation both with patients, but also
with healthcare professionals to maximise the chances of success
(Catwell 2009a; Catwell 2009b).
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Barbanel 2003
Methods Randomised controlled trial
Participants 24 adults from a socioeconomically deprived, ethnically mixed area in the United King-
dom (Tower Hamlets in London) with GP diagnosed asthma
Interventions Following attendance at a 3-day training course on asthma care at the London Chest
Hospital, a number of pharmacists were allocated a group of adults to educate. The
pharmacists then delivered an educational session on asthma topics and reviewed in-
haler technique, and use of a Peak Expiratory Flow Meter, taking a minimum of 45
minutes. They gave the patients supporting literature and a self-management plan. The
pharmacists then phoned the participants on a weekly basis for 3 months in order to
give encouragement, answer questions and encourage patients to return to the pharmacy
with any problems
The control group received no input from the pharmacist
Outcomes Primary outcomemeasurewas asthma symptoms asmeasuredusing theNorth of England
Asthma Symptoms Scale completed at baseline and 3 months after intervention
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Subjects were randomised to intervention or control
groups”
Allocation concealment (selection bias) Low risk “randomised using sealed envelopes”
Blinding (performance bias and detection
bias)
All outcomes
High risk Unable to blind participants from intervention or control
Incomplete outcome data (attrition bias)
All outcomes
Low risk One participantmoved away and their datawere imputed
using appropriate methods
Selective reporting (reporting bias) Low risk No evidence of selective reporting
Other bias Low risk No evidence of other bias
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Bynum 2001
Methods Randomised controlled trial
Participants 15 intervention group adolescents and 21 control group adolescents were recruited in
rural Arkansas, United States, a socioeconomically deprived area which includes Health
Professional Shortage Areas. Adolescents with asthma, ages 12 to 19, predominantly
African-American in origin, were recruited from high schools and randomly assigned to
each group
Interventions Patients received an assessment and training on their use of aMDI via video conferencing:
telepharmacy
Control: Participants were given the manufacturer’s leaflet from the MDI packet
Outcomes 1. MDI technique as assessed against a checklist
2. Patient satisfaction with the technology
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “The participants were assigned to either a telepharmacy
counselling group or a control group using a random
number chart”
Allocation concealment (selection bias) Unclear risk Insufficient information
Blinding (performance bias and detection
bias)
All outcomes
High risk No blinding of outcome assessors, unable to blind from
intervention
Incomplete outcome data (attrition bias)
All outcomes
High risk 49 students were randomised, 36 were available for eval-
uation. Students had different reasons for dropping out,
2 did not attend any visit, 8 had never used the inhaler
and so should not have been randomised as they did not
meet the inclusion criteria 2 students did not attend the
follow up
Selective reporting (reporting bias) High risk Questions 3 and 11 in the satisfaction rating question-
naire were analysed separately following reliability anal-
ysis. This had not been a feature of pre-specified analysis
Other bias High risk Incentive fee of $20 for just the intervention arm of the
study
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Chan 2007
Methods Randomised controlled trial
Participants 120 children aged 6 to 17 with persistent asthma
Interventions This group used an Internet-based asthmawebsite where they could interact with asthma
clinicians. Store and forward, i.e. asynchronous monitoring via the website was used to
collect and to submit a daily asthma diary, inhaler technique video and Peak Expiratory
Flow meter recording twice a week for the first 6 weeks and then weekly thereafter. The
group had 3 face-to-face visits and 3 virtual visits via video technology. Follow up was
conducted by e-mail by the nurse case manager. This was a 12-month study
Control: This group had 6 face-to-face visits with a nurse case manager. The nurse
manager would then contact the patients via telephone 2 times per week for 6 weeks
then weekly to review the asthma action and home management plans and assess the
symptom diary and provide feedback. Control group also received education regarding
their asthma and both groups had 24/7 access to their case manager in case of emergency
Outcomes 1.Therapeutic adherence, i.e. data on use of inhaled corticosteroids
2. Symptom diary adherence
3. Disease control: emergency department visits, hospitalisations, unscheduled asthma-
related clinic visits and use of rescue therapy, i.e. beta agonist inhalers
4. Asthma knowledge scores
5. Paediatric asthma quality of life scores measured for caregivers and for patients. (Pae-
diatric Asthma Quality of Life Questionnaires were Juniper’s AQLQ)
6. Inhaler technique scores for both dry powder inhalers and MDIs with valved holding
chambers
Notes In the selection of patients there was considerable emphasis on the recruitment of “will-
ing” volunteers within the required category of asthma severity and it was checked to
make sure that patients were not planning on moving out of the region during the 12
months of the study. These adjustments could bias the results as the usual attrition seen
in other studies and potentially clinically relevant would be minimised. However, ran-
domisation appears to have been appropriate. The nurse case manager who was assessing
the patients’ inhaler technique was feeding back to the patient and so was not blinded to
the allocation of the patient. Similarly, case manager records were used for the majority
of other outcomes but it is not stated who extracted the data from the records. There
is also an ethical issue in that the computers were removed from the families who were
experiencing virtual visits at the end of the study period - might these families have
become dependent on this technology?
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Patients underwent block randomisation with a table of
random numbers”
Allocation concealment (selection bias) High risk Table of random numbers - not adequately concealed
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Chan 2007 (Continued)
Blinding (performance bias and detection
bias)
All outcomes
High risk Outcome assessors not blinded to allocation of patients
Incomplete outcome data (attrition bias)
All outcomes
High risk From 60 randomised to each arm, only data from 55 in
the control group and 47 in the intervention group were
analysed. Also no diary entry was recorded for 60% to
80% of study days. And recording patterns were different
in each group - patients completed symptomdiary entries
only every 2.8 days in the virtual group and 4.8 days in
the control group
Selective reporting (reporting bias) Low risk No evidence of selective reporting, no deviation from
protocol in reporting results
Other bias High risk Some selection of patients before randomisation, choos-
ing those who would be likely to participate fully in the
study and this gives potential bias to results
Chatkin 2006
Methods Prospective, multicentre, randomised controlled trial
Participants Aged at least 12 with moderate or severe persistent asthma, according to Global Initiative
for Asthma (GINA) in Porto Alegre, Brazil; 271 patients were randomised into 2 groups.
The participants were put forward by physicians from all over the country (it does not
state whether primary or secondary care physicians) for the trial, in this way there were
patients from 15 states of the country
Interventions Both groups received three packages of salmeterol/fluticasone for 3 months supplied
by a drug company and routine care from their own physician. The participants in
the intervention group received a phone call once every 2 weeks to promote treatment
adherence
Control: The control group received initial and final telephone calls for collection of
demographic information only
Outcomes 1. Adherence - percentage of participants taking 85% or more of the prescribed doses of
salmeterol/fluticasone. Adherence was measured according to the number of inhalations
that were recorded on the disks. This was obtained from the disks that were returned to
the office. They excluded patients who did not return the devices
2. The difference in adherence between the control and telephone intervention groups
Notes All participants entered into the study were required to have a residential telephone
number not only a mobile, this may have been a source of bias. In addition, exclusion
criteria were: mild persistent asthma, pregnancy or breast feeding, intention to move
during the course of the study, regular use or recent past abuse of alcohol or illicit drugs
and clinically significant active general medical condition; 4 patients were excluded due
to these criteria. Little informationwas given in the study report regarding randomisation
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Chatkin 2006 (Continued)
and blinding
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information
Allocation concealment (selection bias) Unclear risk Insufficient information
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Insufficient information
Incomplete outcome data (attrition bias)
All outcomes
High risk 10 patients were not included because they
did not return their drug disks and 8 for
not responding to the telephone calls
Selective reporting (reporting bias) Low risk No evidence of selective reporting
Other bias High risk Drugs were supplied for free to the in-
tervention group by a drugs company as
oppose to the real-world situation where
patients would have to pay the high cost
of their inhaler drugs themselves. Also pa-
tients adhere more when they know they
are being monitored, however, this cannot
be controlled for
Clark 2007
Methods Randomised controlled trial
Participants 808 female patients over the age of 18, with physician-diagnosed asthma in theUniversity
of Michigan Health System, United States of America, were randomly assigned to 2
groups. Some of them came from speciality clinics. Patients had to have had active
symptoms in the past 12 months and had been enrolled in one of the participating
asthma related clinics. They were also required to have no extenuating medical or mental
conditions and access to telephone. 424 women were randomised to the intervention
group and 384 to the control group
Interventions Standard asthma education which does not emphasise sex and gender issues was provided
at the time of the clinic visit. The intervention was a behavioural education programme
delivered by a nurse health educator through telephone counselling. Based on social
cognitive theory, women were introduced to a problem-solving process to undertake in
association with their asthma management plan. At baseline the patient’s level of self-
management was determined and then telephone counselling was tailored to that level.
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Sex and gender-role related asthma problems were assessed and women were encouraged
to keep a diary with a Peak Expiratory Flow Meter to monitor their condition. Six edu-
cational telephone calls were made over the 12-month study period to the intervention
women
Control: The usual care group received treatment based on National Asthma Education
Prevention Program guidelines as well as telephone follow up for the purposes of moni-
toring only
Outcomes 1. Frequencies of daytime and night-time asthma symptoms
2. Days and nights that the woman had missed work or study
3. Self-reported emergency department visits, hospitalisations, unscheduled urgent visits
to a clinic and scheduled clinic visits in the 12 months before the study (i.e. at baseline)
and at study follow up, were recorded
4. Medical record data for asthma emergency department visits and hospitalisation from
a Data Warehouse during the corresponding time periods
5. Sex and gender role-related queries were made relating to symptoms and themenstrual
cycle, pre-menstrual syndrome, contraceptive pill, hormone replacement therapy and
urinary incontinence. Asthma problems relating to housework, washing or cleaning
products, fragrances, cosmetics and hair products, exposures through child care and
symptoms associated with social and sexual activity
6. The Juniper’s Mini Asthma Quality of Life Questionnaire was used to measure a
woman’s quality of life
7. A scale of self-confidence for asthma management
8. The Zimmerman Scale was used to assess the level of a woman’s self-regulation ability
Notes The authors acknowledge that more women with persistent asthma were assigned to the
treatment group (P = 0.003) The impact of this is difficult to anticipate: as the women
in the intervention group were sicker, it may have limited the impact of the intervention.
Conversely, the intervention may have been perceived asmore effective as the women had
greater scope for improvement. The major potentially confounding variable of smoking
was not assessed in this study; data on smoking rates were not collected
Medical record data were collected for the corresponding time periods and compared
with self reports - data triangulation
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “randomisation processes were based on random length
permuted blocks”
Allocation concealment (selection bias) Unclear risk Insufficient information
Blinding (performance bias and detection
bias)
All outcomes
Low risk “Participants’ physicians were blind to the assignment of
their patients in this study”
“Data collectors were blind to the assignment of the
women to the study arms”
It would not have been possible to blind the women from
the group allocation
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Incomplete outcome data (attrition bias)
All outcomes
Low risk “There were no differences in dropouts due to demo-
graphic variables, disease severity and important out-
comes between the two groups.”
Selective reporting (reporting bias) Low risk All of the study’s pre-specified outcomes are reported
Other bias High risk “It happened that more women with persistent asthma
were assigned to the treatment group. As noted this fact
could have made intervention results more difficult to
achieve given that the women were sicker conversely it
could have provided more room for women to improve.
”
Smoking rates were not assessed
Cruz-Correia 2007
Methods Randomised cross-over study
Participants 21 adults aged 16 to 65, from Porto, Portugal, with a previous medical diagnosis of
asthma were included
Interventions Patients received web-based monitoring for 4 weeks then paper monitoring for 4 weeks
or vice versa in random sequence - a cross-over trial. The web-based application was
named “Portal for Assessment and Self-management of Asthma” and it included infor-
mation on frequently asked questions, asthma self-management and enabled patients to
fill in the Asthma quality of life test and record PEF/FEV1. The technology provided
immediate feedback, automatic messages and alerts to both patients and doctors to en-
able therapeutic decisions. This information contributed to an interactive asthma plan
Control: The control group recorded PEF/FEV1 in a paper diary and had a paper based
action plan
Outcomes Outcome measures
1. Patient opinions, in the form of positive and negative comments, reports of problems
relating to the internet connection, importance of different features that the different
diaries offered and patients’ willingness to monitor their asthma
2. The time taken to fill in the internet and paper diaries
3. Adherence to monitoring tools
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Randomisation was performed using a computer gen-
erated algorithm”
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Cruz-Correia 2007 (Continued)
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
High risk No blinding, both patients and data collectors un-
blinded
Incomplete outcome data (attrition bias)
All outcomes
High risk Twopatients dropped out, one lost access to the Internet
during the study period the other moved to another city
Selective reporting (reporting bias) High risk Data collected on quality of life but not reported
Other bias High risk Some patients reported filling in their paper diaries for
several days at once, this was not possible with the In-
ternet system
de Jongste 2009
Methods Prospective, open-label, randomised, multicentre, parallel-group trial
Participants 151 children aged 6 to 18 years with stable mild/moderate asthma treated with 200 to
1000microgramof inhaled budesonide or equivalent for 2months before randomisation,
recruited from 5 academic centres and 12 general hospitals. Children had RAST class 2
or higher or a positive skin prick test for at lease one airborne allergen
Interventions The intervention group received an nitric oxide airway inflammationmonitor to perform
measurements daily. Data were transmitted to the co-ordinating centre. All children
(intervention and controls) recorded symptomson apalmtop electronic diary. All parents
were phoned every 3 weeks between visits and medication was adapted according to
mean nitric oxide and cumulative symptom scores over the previous 3 weeks
Outcomes Children of both groups were seen at randomisation and at 3, 12, 21 and 30 weeks. All
parents were phoned every 3 weeks between visits and medication (steroids) was adapted
according to an algorithm which included symptoms and mean expired nitric oxide
1. Expired nitric oxide was performed before and after salbutamol, as ameasure of airways
inflammation
2. Adverse events were recorded
3. Pediatric Asthma Caregiver Quality of Life Questionnaire with Standardized activities
was administered at first and last visits
4. Primary end point was change from baseline of percentage symptom-free days during
the last 12 weeks
5. FEV1 and reversibility
6. Prednisone courses
7. Emergency visits
8. Hospitalisations
Notes All nitric oxide analysers were checked for drift. Intention-to-treat analysis was performed
for all subjects who were enrolled. In addition they performed a per protocol analysis
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Children were randomised at their first
visit, stratified by centre
Allocation concealment (selection bias) Unclear risk Insufficient information
Blinding (performance bias and detection
bias)
All outcomes
High risk No blinding
Incomplete outcome data (attrition bias)
All outcomes
High risk Four children, 2 for non-compliance, 1 for
inappropriate inclusion (no allergy) and 1
for moving abroad and being unable to
transfer data. Therefore study population
for evaluation was 147 children
“Only periods with at least 50% valid daily
scores were analysed.” Is later explained
as 79% valid diary entries over the whole
study period. It is not explained what is
done for the remaining periods
Selective reporting (reporting bias) High risk Full details of number of emergency de-
partment visits are not reported
Other bias High risk Children only recruited from academic
centres or general hospitals therefore may
not be receiving standard primary care
Donald 2008a
Methods randomised parallel group trial
Participants This Australian study recruited 71 adults aged between 18 and 55 years who had been
admitted to one or both of 2 teaching hospitals with a primary diagnosis of asthma.
Adults were excluded if they had another chronic respiratory condition, an unstable
medical condition, a cognitive or intellectual disability, psychiatric illness or were unable
to speak English. All patients received a Peak Expiratory Flow (PEF) meter and identical
instructions on how to record their results
Interventions All participants received a PEFmeter and instructions on how to record their results. The
nurse then used the first week’s record to determine the participant’s best PEF rate. All
participants attended a face-to-face session with an asthma nurse educator and received
advice on the pathophysiology of asthma, medications, triggers and self management.
They were then provided with an Asthma Action Plan
The intervention group received 6 follow-up telephone calls from the nurse educator to
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ask about their current asthma symptoms and give advice on their management
Control: The control groupwas encouraged to continue with self-management and usual
GP care
Outcomes 1. Hospital admissions at recruitment
2. Written plan and PEFM ownership
3. Delivery of management sessions
4. Health care utilisation
5. Days lost from work or study
6. Exacerbations requiring use of oral corticosteroids
7.Costs from the healthcare perspective, i.e. costs of providing the intervention compared
with differences in outcomes between the intervention and control groups
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information
Allocation concealment (selection bias) Unclear risk Insufficient information
Blinding (performance bias and detection
bias)
All outcomes
Low risk “All participants were telephoned weekly by a re-
searcher (blinded toparticipant allocation)”.However,
neither the participant nor the nurse were blinded to
allocation - they could not be
Incomplete outcome data (attrition bias)
All outcomes
High risk Study is under-powered. A sample of 100 patients had
been calculated to provide statistical power, however
only 71 participants were randomised and only 44
replies received at 6 months and 49 at 12 months. No
report of howdataweremodified given that fewer than
required by power calculation filled in questionnaires
at 6 and 12 months
Selective reporting (reporting bias) Unclear risk ? use of unusual statistical tests to modify data
Other bias High risk 660 patients were assessed for eligibility, 385 were not
contactable, 154 declined to participate, 31 were ex-
cluded and 19 failed to attend the baseline meeting.
There needs to be consideration of selection bias, how-
ever, as the authors recognise, 55% of potential partic-
ipants could not be contacted therefore their reasons
for not taking part cannot be established nor can their
characteristics be compared to the study group
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Methods This was the same study as Donald 2008a with additional data and calculations performed with regards to cost, i.e.
outcome 7 in the above table
Participants -
Interventions -
Outcomes -
Notes -
Gruffydd-Jones 2005
Methods Randomised controlled trial
Participants 194 patients were recruited from a General Practice in England. If the patient was aged
17 to 70 and on the practice asthma list they were eligible. Exclusion criteria were being
housebound, refusing consent and not having a telephone
Interventions Intervention: Patients were telephoned at 6-monthly intervals by an asthma nurse who
asked the Royal College of Physicians’ 3 risk stratification questions:
In the last month/week:
1. Have you had difficulty sleeping because of your asthma symptoms (including cough)
?
2. Have you had your usual asthma symptoms during the day (cough, wheeze, chest
tightness or breathlessness)?
3. Has your asthma interfered with your usual activities?
The patient was also asked 2 extra questions related to a high risk of asthma death
1. Have you ever needed treatment in intensive care for your asthma?
2. Have you been admitted to hospital with your asthma within the last year?
If patients answered “no” to all these questions they were considered low risk and an
Asthma Action Plan was formulated with advice regarding what to do if control deterio-
rated. If patients answered yes to any question they were deemed “high risk” and a clinic
visit arranged. When control was stable for 3 months patients returned to telephone
asthma review
Control: “Usual care” consisted of 6-monthly check-ups (at baseline, 6 months and 12
months) by asthma appointment with a diploma level asthma nurse. Symptom scores,
inhaler technique and PEF meter measurements were checked and patients given an
Asthma Action Plan. Follow up was according to clinical need and reminders were issued
to defaulters
Outcomes Outcome measures:
1. 6-question Asthma Control Questionnaire
2. Mini-asthma quality of life questionnaire
3. Evidence of mild exacerbation (increase in the number of times the reliever was used
above baseline of > 1, on 2 consecutive days)
4. Evidence of severe exacerbation (oral steroid use or hospitalisation)
5. Economic evaluation from the perspective of the NHS
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Notes This study only involved one practice which may mean that the results are of limited
generalisability. In addition the power of the study was reduced by high uneven drop-
out rates across the groups. Another source of bias is the fact that the assessors were
not blinded to which group the patients had been randomised to. However, this study
is representative of real-world conditions when there are high non-attendance rates for
asthma follow-up interventions
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Patients were randomised using random number tables
on a one to one basis and stratified according to severity
Allocation concealment (selection bias) High risk Random number tables unlikely to conceal allocation
Blinding (performance bias and detection
bias)
All outcomes
High risk “It was not possible to blind the patients or nurses to the
groups into which the patients were randomised”
Incomplete outcome data (attrition bias)
All outcomes
Low risk There were 20 withdrawals in the control group after the
first visit, mainly due to non-attendance and 6 in the tele-
phone group, one of which was due to non-attendance.
As this trial is as real-world as possible the fact that there
was a high non-attendance rate was taken account of in
analysing the costs
Selective reporting (reporting bias) Low risk No evidence of selective reporting
Other bias Low risk Careful account is taken of the non-attendance and a
post-hoc analysis performed to consider the possibility of
attrition bias
Guendelman 2002
Methods Randomised controlled trial
Participants Patients: 134 patients were recruited from a primary care clinic in California, United
States of America. Children were eligible for inclusion in the study if they were 8 to 16
years of age, had an English-speaking caregiver, a telephone to the house and persistent
asthma
Interventions Intervention: Patients first received a teaching session on PEF measurement and how to
manage their medication according to the result. Children were then randomised. The
intervention group received the Health Buddy device, a computerised interactive asthma
self-management and education program which connected to the Internet and asked
every day about asthma status, peak flow and medication. Responses were downloaded
to the nurse co-ordinator overnight. The devices were interactive and gave immediate
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feedback on questions regarding asthma symptoms, medications, PEF and other items
Control: The control group used a paper asthma diary. All children returned for 2 follow-
up visits at 6 and 12 weeks when they received further standardised teaching from the
nurse co-ordinator
Outcomes Outcome measures
1. Limitation in activity
2. Asthma symptoms including coughing and wheezing
3. Missed school days
4. PEFR in yellow or red zone i.e. sub-optimal, below the normal (green) zone
5. Healthcare utilisation: emergency department visits or hospitalisations
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information, “randomised”
Allocation concealment (selection bias) Low risk “Following baseline interview the nurse opened a sealed
envelope containing the treatment assignment”
Blinding (performance bias and detection
bias)
All outcomes
High risk Self-reported outcomes were assessed by the nurse co-
ordinator, no blinding
Incomplete outcome data (attrition bias)
All outcomes
Low risk “Baseline characteristic of children who did and did not
complete the trial did not differ”, 66 patients were ran-
domised to the intervention group and after 12 weeks
62 patients remained. 68 patients were randomised to
the control group and after 12 weeks only 60 remained.
Reasons for dropping out of the study included moving
out of the area n = 3 or life crisis n = 4. 5 familles who
dropped out were uncontactable
Selective reporting (reporting bias) Low risk All primary and secondary outcomes are reported
Other bias High risk Incentive fees were paid to study participants; may limit
generalisability of study
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Methods Randomised controlled trial
Participants This study was conducted in Taiwan where 73% of adults have personal computers
and 54% of families have internet access. Children were eligible for inclusion in the
study if they were between the ages of 6 and 12 years, had access to the Internet by
their caregivers and had a physician’s diagnosis of asthma. Other chronic conditions
such as bronchopulmonary dysplasia were excluded. 164 paediatric asthma patients were
enrolled
Interventions The intervention group participants were given “Blue Angel for Asthma Kids”, an In-
ternet-based paediatric asthma monitoring program for asthmatic children plus their
parents. The system has symptom and peak flow diaries and individual Asthma Action
Plan suggestions based on the GINA (Global Initiative for Asthma) guidelines. These
data can be shared with the patient’s physician who can give feedback via telephone or
email. The peak flow meter provided to the families could measure PEF and FEV1 and
attached via a USB (Universal Serial Bus) connection to a computer
Control: Traditional treatment in an outpatient allergy and asthma clinic accompanied
by a PEF meter and diary. This group also received asthma education as part of usual
care including verbal and printed information. They were also given an Asthma Action
Plan to aid decision making
Outcomes Outcome measures:
1. PEF records
2. Symptom diaries
3. Paediatric Quality of Life test was completed at baseline and after 12 weeks
4. Childhood Asthma Control Test, at baseline and 12 weeks
5. Caregiver Survey of Asthma Knowledge, before and after the trial
6. Measurement of patients’ adherence to treatment
7. Adherence to asthma diaries
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “children and their caregivers, who were randomised”
Allocation concealment (selection bias) Low risk Sealed envelope
Blinding (performance bias and detection
bias)
All outcomes
High risk No information is given as to how the outcomes of the
groups were collected and whether outcome assessors
were blinded to the allocationof the patients. Thiswould,
of course, not have been possible for the outcomes that
were recorded by the Internet program but other out-
comes which were recorded using questionnaires at base-
line and 12 weeks
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Incomplete outcome data (attrition bias)
All outcomes
High risk Study power calculation required 100 children in each
arm. 99 were randomised to the intervention arm and 97
were randomised to the control arm
Of the original sample of 196 children there were 184
invited to participate. 5 families were “too busy”, “ not
interested” or found it “too complex to perform the diary
card” 15 (6 control and 9 intervention participants) were
excluded either at their request or because there was a lack
of data due to internet failure. 7 families who dropped
out were unavailable for comment
“baseline characteristics of childrenwhodidnot complete
the trial did not differ from those who did”
The study reports that 82 intervention participants and
71 control participants returned for 12-week follow up.
This leave 4 participants unaccounted for
Selective reporting (reporting bias) High risk Satisfaction questionnaires data not shown
Other bias Low risk No other bias apparent
Khan 2004
Methods Randomised controlled trial
Participants 310 children with asthma who were discharged from a hospital emergency department
in Sydney, Australia
Interventions Parents of children in the intervention group received a telephone consultation by an
experienced asthma nurse educator within 2 weeks of discharge. This consultation em-
phasised the advice given to the parents at the time of discharge. These calls lasted an
average of 13 min (range 5 to 44 minutes). Parents of both the intervention and control
groups received written materials regarding facts about asthma, use of spacers, manage-
ment of exercise induced asthma and when to contact a doctor
Control: This group did not receive the follow-up telephone call, however they did
receive written material regarding asthma at baseline, before their discharge from the
emergency department
Outcomes Outcome measures:
1. Number of days of wheezing in the last 3 months
2. Possession and use of a written asthma action plan during a crisis
3. Use of preventer medication
4. Increased asthma knowledge scores (Newcastle Asthma Knowledge Questionnaire)
5. Parental quality of life scores (Juniper Caregiver’s Quality of Life Questionnaire)
6. Number of visits to GP/paediatricians
7. Number of attendances at emergency department and admissions to hospital with
asthma in the previous 6 months
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Notes This study may have had insufficient power to show real differences between the groups
as the children mainly had mild episodic symptoms. The context of following up an
emergency department visit is also important, as it can be considered as a kind of “window
of opportunity” to educate patients and children and parents in both arms by giving them
written and verbal information regarding control of asthma. The effect of this is that
patients and their parents may be more receptive to the messages regarding medication
adherence and control in the acute situation
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “An asthma educator randomly assigned children to ei-
ther intervention or control using a list of random num-
bers that had been provided to her”
Allocation concealment (selection bias) Unclear risk “children’s details were faxed to an asthma educator work-
ing in New South Wales” sounds as though this might be
an attempt at central randomisation but this is not made
explicit
Blinding (performance bias and detection
bias)
All outcomes
Low risk Outcome assessment by postal questionnaire, therefore
single-blinded. Not possible to blind participants to in-
tervention
Incomplete outcome data (attrition bias)
All outcomes
Low risk 310 children enrolled in study, 266 (86%) completed
the follow-up questionnaire. 22 had changes their ad-
dress and 22 were non-responders. 130 control children
completed follow up and 155 intervention children com-
pleted follow up. “Children lost to follow-up were similar
demographically and in terms of asthma severity when
compared to those who completed the study”
Selective reporting (reporting bias) Low risk “All analyses were specified a priori”
Other bias High risk 49%of parents were excluded (exclusion criteria not pub-
lished). Parents whose English was inadequate to com-
plete the questionnaires were also excluded, this might
mean that the population in greatest need were excluded
as non-English speakers are often socioeconomically de-
prived populations
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Methods Randomised controlled trial
Participants Patients: This study looked at 53 patients, all adults with asthma, in 2 parallel groups, in
Japan. 26 were randomised to the intervention group, 27 to the control group. Patients
were included if they had visited the emergency department more than twice in the last
year. Exclusion criteria excluded patients with COPD, heart failure and other diseases
as potential confounders
Interventions Intervention: A telehealthcare system was set up with an electronic Peak Flow Meter
which measured both PEF and FEV1 and could store up to 500 readings in its memory.
The nurse introduced the patients to the system and then provided telephone follow up
available 24 hours if required. The nurse was overseen by a physicianwho had determined
the patient’s best PEF and written an asthma plan. The nurse reported to the physician
monthly according to the data they received from the meter. The physician saw the
patient regularly to review the action plan
Control: No information given
Outcomes Outcome measures:
1. Reduction of emergency visits during the day and at night
2. Improvement in activities of daily living
3. Frequency of lung function testing and data transmission
4. Peak Expiratory Flow Rate
Notes This was very hard to assess given the limited translation of this studywhichwas available.
The majority of figures and graphs were in English and the limited translation for
Cochrane stated “no description” for most of the relevant headings
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information
Allocation concealment (selection bias) Unclear risk Insufficient information
Blinding (performance bias and detection
bias)
All outcomes
High risk No blinding
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Insufficient information
Selective reporting (reporting bias) Unclear risk Insufficient information
Other bias Unclear risk Insufficient information
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Methods Randomised controlled trial
Participants Patients: 75 adults with asthma, in Japan, were studied in an intervention group of 37
initially (reducing to 32) and a control group of 38 (reducing to 34). Patients were
recruited from 17 medical institutions, a multi-centre trial over a period of 6 months.
Patients were selected who had visited the night emergency department room 3 times or
more within a year in spite of corticosteroid therapy
Interventions This group was managed with telehealthcare. The nurse under the physicians’s supervi-
sion monitored the patient at home via telephone, providing them with advice in man-
aging exacerbations and proper use of a controlled management plan
Control: Standard out-patient care without telehealthcare
Outcomes Outcomes:
1. Hospitalisation, night and daytime emergency department visits
2. Patient compliance with daily PEF measurement and medications
3. Patient compliance with prescribed medications
4. PEFR
5. Quality of life
6. Economic effectiveness, although this was not compared between intervention
and control group
Notes As with Kokubu 1999, this was again a limited translation of this study and so risk of
bias was very hard to assess. The majority of figures and graphs were in English and so
the results can be gleaned from these
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation was done with telephone to the registra-
tion centre
Allocation concealment (selection bias) Unclear risk Insufficient information
Blinding (performance bias and detection
bias)
All outcomes
High risk “non-blinding method”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk The intervention group began as a group of 37, reducing
to 32 and the control group of 38, reducing to 34 but no
reasons for this are given
Selective reporting (reporting bias) Unclear risk Insufficient information
Other bias Unclear risk Insufficient information
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Ostojic 2005
Methods Randomised controlled study
Participants 16 patients with asthma from a respiratory clinic, in Croatia, 9 males, mean age 24.6
+/- 6.5 years, were enrolled. All had asthma and all had experience of Global System
for Mobile Communications’ Short Message Service (GSM SMS, i.e. text). Exclusion
criteria included a history of smoking, chronic bronchitis or emphysema or inconsistent
access to a cell phone with text.
Interventions Following a 1-hour education session with a specialist at the clinic during which they
discussed symptoms of asthma, and their inhaler technique was addressed, the patients
were given a Peak Flow Meter and instructed in its use. Patients were told to note PEF,
medication use and symptoms in a paper diary. PEF was to be done 3 times a day,
then those patients in the text group would send their results daily to a computer in
the asthma centre. Both groups were treated according to GINA guidelines but the text
group received weekly instructions by text from an asthma specialist on adjustments of
therapy and invitations, when required, to come in for an extra office visit
Control: The controls also kept a daily diary of peak flow and symptoms, however their
results were only reviewed by the physician at the end of the study period on attending
the physician’s office
Outcomes Outcomes:
1. Office pulmonary function test measurements
2. Patient’s daily records of PEF and symptoms
3. Details of asthma medication
4. PEF variability (defined as the difference between the maximal and minimal PEF
measurements of a day divided by the maximal PEF for that day)
5. Cost and reliability of text
Notes As this was a very small study of only 16 patients all of whom were young and already
familiar with text and none of whom smoked it already presents a somewhat biased
picture of the asthma population. This is reflected in the 99% compliance rate with
the text transmission of PEF rate measurements. In a more representative sample of the
general asthmatic population you would anticipate this figure to be much lower. This
is the major weakness of this study. There was also no blinding in the study, however
efforts were made to randomise appropriately
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Patients were randomised by computer”
Allocation concealment (selection bias) Unclear risk Insufficient information
Blinding (performance bias and detection
bias)
All outcomes
High risk In does not appear that outcome assessors were blinded
as to patient allocation. It would have been impossible
to blind patients as to intervention
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Incomplete outcome data (attrition bias)
All outcomes
Low risk No evidence of incomplete outcome data; there were
no study withdrawals
Selective reporting (reporting bias) Low risk No evidence of selective reporting
Other bias Low risk No evidence of other bias
Pinnock 2003
Methods Pragmatic, multicentre, randomised controlled trial
Participants 278 people with asthma (people who had requested a prescription for a bronchodilator
inhaler in the last 6 months) were contacted for asthma review at four UK general
practices. None of these adults had been reviewed in the previous 11 months
Interventions Telephone review was used for 137 patients, with the asthma nurse. The nurse tried up
to 4 times to contact the patients
Control: Face-to-face reviews for 141 patients in the surgery also with asthma nurse, one
invitation was sent in the usual manner. Content of the review was as the nurse deemed
appropriate
Outcomes Outcomes:
1. Comparisons were made of the proportion of patients reviewed in each arm within
three months of randomisation
2. Time taken to review patients in each, arm i.e. length of consultation
3. Asthma morbidity according to the validated “short Q” score
4. Asthma related quality of life as measured by the Juniper mini asthma quality of life
questionnaire
5. Patient satisfaction of nursing care
6. Overall cost of respiratory care from the perspective of the NHS. This included costs
of the healthcare professionals, any hospital costs (respiratory outpatients, accident and
emergency, hospital admissions), as provided by the Personal Social Services Research
Unit. This included cost of all respiratory care, surgery, telephone, home visits and out
of hours care for all respiratory conditions as recorded in the patients’ notes. Prescribing
costs from the British National Formulary. All costs were in pounds sterling for the year
2000-2001
7. Total cost of providing the review service, including costs of the asthma specialist
practice nurse (source: Personal Social Services Research Unit) and Telephone costs
(British Telecom)
8. Cost per consultation achieved in the 2 groups and also costs per missed appointments
and telephone calls that were not answered
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
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Pinnock 2003 (Continued)
Random sequence generation (selection
bias)
Low risk Patients were centrally randomised in
blocks of 10 to ensure that approximately
equal numbers of patient were allocated to
each arm of the study
Allocation concealment (selection bias) Low risk Central randomisation
Blinding (performance bias and detection
bias)
All outcomes
High risk “a researcher, blinded to allocation vis-
ited each of the practices and validated a
random 20% sample of consultation data
and data retrieved from records”. Although
the patients and investigators could not
be blinded to the interventions and, in
most cases the outcome assessors, were not
blinded to group allocation either, this was
an attempt to ensure that outcome data
were not biased
Incomplete outcome data (attrition bias)
All outcomes
Low risk The proportion of patients reviewed by
each of the researchmethods was a primary
outcome measure and was clearly reported
Selective reporting (reporting bias) Low risk No evidence of selective reporting
Other bias Low risk No evidence of other bias
Pinnock 2005
Methods This was the same study as Pinnock 2003 with additional data and calculations performed with regards to cost, i.e.
outcomes 6 to 8 in the above table
Participants -
Interventions -
Outcomes -
Notes -
Pinnock 2007
Methods Phase IV Implementation study (as per Medical Research Council 2008)
Participants Patients: One large English general practice on 3 sites was involved in this trial. During
the 12-month study patients with asthma were offered a review service according to the
allocation of the group with which they were registered
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Pinnock 2007 (Continued)
Interventions Intervention: The patients who were allocated to the intervention group were given a
telephone option for their asthma review service. They were identified from the practice
computer database and sent 3 invitations over the study period. They could book either
a telephone or face-to-face review both at a pre-arranged time. Patients who did not
respond to the 3 invitations were phoned and reviewed opportunistically
Control: The control group were recalled to face-to-face only asthma reviews using invi-
tations by post or as memos with repeat prescriptions. There was no option of telephone
reviews and no systematic attempt was made to phone non- attenders opportunistically.
There was a second control arm of usual care who had an established asthma clinic with
no systematic recall. Invitations would only be issued in response to clinical need
Outcomes Outcomes:
1. Proportion reviewed: proportion of patients with active asthma who had received a
dedicated asthma review within the previous 15 months
2. Asthma morbidity and enablement, as assessed by the following postal questionnaires:
mini asthma quality of life questionnaire, Asthma Control Questionnaire, Modified
Patient enablement Instrument and Asthma Bother Profile
3. Adverse events, both clinical, e.g. asthma deaths and near-fatal asthma attacks and
organisational, e.g. complaints
4. Time, cost and mode of review were all documented
Notes The population was not fixed in this implementation study as in a trial, therefore new
diagnoses, changes in disease status, moves into and away from the practice were all
included in the allocated service provision of the group with which they were registered
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Allocation was decided by the toss of a coin
Allocation concealment (selection bias) Unclear risk Insufficient information
Blinding (performance bias and detection
bias)
All outcomes
High risk The nurses were aware of allocation, how-
ever there were quality control checks
blinded to allocation which confirmed ac-
curacy of data transfer
Incomplete outcome data (attrition bias)
All outcomes
Low risk Real-world implementation study, there-
fore the uptake rate by patients is part of the
study, routine asthma review was provided
for 66.3% of patients in the telephone only
group and 53.8% in the face-to-face only
group
Selective reporting (reporting bias) Low risk No evidence of selective reporting
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Pinnock 2007 (Continued)
Other bias High risk Randomisation only took place in 2 of the
3 practices due to various considerations
Rasmussen 2005
Methods Randomised controlled trial with one intervention arm and 2 control arms
Participants Patients: This study was set in Copenhagen, Denmark. In 2001, a random sample of
subjects was sent a questionnaire to diagnose asthma. A power calculation was performed.
Letters were posted until 300 adults aged 18 to 45 had been diagnosedwith asthma on the
basis of a combination of respiratory symptoms and at least one objective measurement
(i.e. hyperresponsiveness to methacholine or peak expiratory flow variability)
Interventions Intervention:This groupwere given electronic diary, an asthma action plan and a decision
support system for the physician. Patients were given a Peak FlowMeter and taught how
to fill in a daily diary and respond to the computer’s advice. Physicians gave instructions
via e-mail or telephone to the participant
Control 1. Specialist care: The specialists taught the patients how to adjust their medi-
cation on the basis of a peak flow meter and written action plan
Control 2: GP: The GP group were asked to contact their GP and pass on a letter
describing the study and giving the test results. GPs in Copenhagen had been sent a
circular about asthma and GINA guidelines in the past
Outcomes Outcomes:
1. Quality of Life as assessed by AQLQ
2. Other questionnaire based outcomes: asthma self-care, smoking, education, salary,
sick leave and hospitalisations. Respiratory symptoms current medication, compliance
and adverse reactions
3. Lung function as carried out at baseline and 6 months and airway responsiveness with
methacholine
Notes The selection of participants was unusual as they came directly from the community and
not from previous diagnosis by a physician or GP as in most other studies. This has the
benefit of standardised diagnosis and avoids under-diagnosis which may be a problem
in the general population, however it may have implications when synthesising results
from other studies. Participants in all 3 groups had to cover the costs of the medication
prescribed, this may have been a problem for some patients and caused a bias
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk “Patients were randomised consecutively”
Allocation concealment (selection bias) Low risk “sealed envelope technique”
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Blinding (performance bias and detection
bias)
All outcomes
High risk Impossible to blind participants and no ev-
idence of attempts to blind outcome asses-
sors or data analysers
Incomplete outcome data (attrition bias)
All outcomes
High risk Of the 300 patients randomised, 253 pa-
tiens completed both the screening and fol-
low-up visits
Selective reporting (reporting bias) High risk Not all of the results from the question-
naires above are reported
Other bias High risk See notes above
Van der Meer 2009
Methods Randomised controlled trial
Participants 200 adults with physician-diagnosed asthma, age 18 to 50, prescription of inhaled cor-
ticosteroids for at least 3 months in the previous year
Interventions There was a 2-week baseline period where patients familiarised themselves with the tech-
nology before randomisation. Then patients who were randomised to receive interven-
tion used an Internet-based self-management program. They measured FEV1 daily and
reported the highest of 3 measurements before taking their medication. They complete
the Asthma Control Questionnaire (ACQ) once a week and reported symptoms via in-
ternet or text. Patients monitored their asthma using the special website or via text on a
mobile phone then used an Internet-based asthma treatment plan and online education,
including asthma news, frequently asked questions and other information. Patients could
also communicate with a specialised asthma nurse either using the web or telephone.
The ACQ score fed into an algorithm and patients received one of 4 treatment messages
Control patients had access to the part of the website on which a diary of symptoms and
exacerbations was kept
Outcomes 1. Educational outcomes including asthma knowledge assess via the 12-item Consumer
Asthma Knowledge Questionnaire
2. Inhaler technique (standardised checklist of the Dutch Asthma Foundation)
3. Average number of medication changes per patient
4. Healthcare provider contacts including physician visits, telephone contacts and web
communications
5. Clinical outcomes including 32-item Juniper adult AQLQ, Asthma Control Ques-
tionnaire, symptom-free days, pre-bronchodilator FEV1, daily inhaled corticosteroid
dose and exacerbations
Notes The study was performed in Dutch. It would have been useful to know the seasonal time
of year at which the results were recorded as asthma can worsen in cold weather or with
pollen counts
Risk of bias
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Van der Meer 2009 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “patients were randomly assigned using a computer-gen-
erated permuted-block scheme”
Allocation concealment (selection bias) Unclear risk “Allocation took place by computer after collection of
the baseline data ensuring concealment of allocation.” It
is not clear whether this was central allocation
Blinding (performance bias and detection
bias)
All outcomes
High risk No blinding of intervention, outcome assessor or data
analyser
Incomplete outcome data (attrition bias)
All outcomes
High risk 200 adults were randomised, after 12 months there re-
mained 92 in the control group and 91 in the interven-
tion group. 9 patients withdrew consent and 8 were lost
to follow up. They analysed complete cases and did not
impute missing values
Selective reporting (reporting bias) Low risk No evidence of selective reporting
Other bias Low risk No evidence of further systematic bias
Vollmer 2006
Methods Randomised clinical trial
Participants Patients: Central to this study was the aim of identifying individuals at greatest risk for
acute exacerbations. Patients from Kaiser Permanente Northwest KPNW, a large group
health maintenance organisation in Portland Oregon, were used for this study. Patients
were eligible if they were aged 18 or older on January 1st 2003 and were on the KPNW
asthma registry or had had at least 180 days of anti-asthma medication dispensed. 850
individuals who had COPD listed on their problem list were excluded. Resulting sample
size was 6948 patients
Interventions Intervention: This consisted of 3 rounds of telephone calling about 5 months apart. The
calls consisted of a series of questions to assess any recent emergency care for which they
had not had follow up; their current stage of asthma control and medication use and
whether they could identify a primary care provider whom they usually saw for asthma
care. Patients were asked questions to screen for COPD. Next they were given optional
tailored feedback regarding their overall level of asthma control and use of medications.
Suggestions might include advice on the control of night waking or the need to continue
inhaled corticosteroids daily. An offer of further KPNW services and a repeat call in
5 months was given. 3389 patients received calls using automated speech recognition
technology. 192 patients received the call from a live caller. The call generated alerts for
the provider as to which participants were at high risk of a future exacerbation, thereby
hopefully triggering follow up
Controls: Received usual care, i.e. no additional telephone calls
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Vollmer 2006 (Continued)
Outcomes Primary outcome measures: data were collected by surveys of patients and a selection
of providers. Baseline data came from administrative data, KPNW data and a survey
mailed to a random sample of 549 health plan members in November 2002. This had
an 83% response rate. Follow-up data came from a survey of 1583 randomly selected
participants 1 month after final call, response rate 65%
1. Healthcare utilisation (KPNW data)
2. Medication use (Asthma Therapy Assessment Questionnaire (ATAQ), dispensing of
antiasthma medications)
3. Quality of life (ATAQ, 5-point scale reflecting the number of control problems in
the last month, mini-Juniper Asthma Quality of Life Questionnaire and Asthma Impact
survey)
4. Demographic data, measures of health status, self-management practices, attitudes
about asthma and satisfaction with care
Notes At first the strength of this study seems to be its large number of participants. However,
on closer inspection it transpires that the data sources are often fragmented and chosen
as representative data or randomly selected representative group rather than actual data
from the full number of participants. Little effort seems to have been made to confirm
that the samples used were indeed representative of the groups they were selected to
represent, i.e. no confirmation of baseline data etc
In addition, the very low participation rate in the intervention calls is a high risk factor
for the introduction of bias
Also of note was the ethically dubious decision not to inform participants that they were
taking part in research. The authors justified this by stating this was ”in order to mimic
the results of real-world implementation.”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information
Allocation concealment (selection bias) Unclear risk Insufficient information
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk No detail given as to who amassed results from question-
naires and whether blinding procedures were in place
Incomplete outcome data (attrition bias)
All outcomes
High risk Outcome data was only collected from a random sample of
both the intervention and usual care groups, i.e. incomplete.
For healthcare utilisation data, it was only reported for pa-
tients who had had at least 6 months of cover by the plan
Selective reporting (reporting bias) High risk “although the overall intent-to-treat analyses gave non sig-
nificant results, post hoc analyses that compared the control
participants to participants who actually used the interven-
tion found numerous significant, albeit small differences.”
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Vollmer 2006 (Continued)
Other bias High risk Very low participation rates in intervention. Follow-up data
were collected from only 38% of participants
Willems 2007a
Methods This paper reported process outcomes from the study whose full results were published in Willems 2008
Participants -
Interventions -
Outcomes -
Notes -
Willems 2007b
Methods This paper reported cost effectiveness of the study whose full results were published in Willems 2008
Participants -
Interventions -
Outcomes -
Notes -
Willems 2008
Methods Single-centre, prospective, randomised controlled trial
Participants Maastricht in the Netherlands, 56 children and 53 adults, 42% of the children and 50%
of the adults were female. Mean ages: children,11: adults, 46
Interventions Intervention group used an asthma monitor with modem at home with an asthma nurse
as the main caregiver, i.e. a telemonitoring kit based on peak-flow measurements. There
was a baseline visit to the asthma nurse when the patient received education about the
telemonitoring protocol. Patients were asked to perform daily PEFR and more often in
exacerbations. The nurse could increase and decrease asthma medication and involve a
doctor if necessary
Control group received regular outpatient care: 3 to 6-monthly medical check-ups by
their lung specialist or paediatrician
Outcomes 1. Diary of clinical asthma symptoms (cough, sputum production, shortness of breath
and wheezing)
2. Asthma-related medical consumption (health care utilisation and self-reported medi-
cation use)
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Willems 2008 (Continued)
3. Feasibility as assessed by ease of recruitment, and by the occurrence of technical and
logistic problems
4. Spirometry data - which could be stored and analysed after several weeks as themonitor
had a sufficient memory
5. Quality of life: as assessed by questionnaires - European Quality of Life-5D, Short
Form 36, Asthma Quality of Life Questionnaire, Paediatric Asthma Quality of Life
Questionnaire and Health Related Quality of Life Measure for Children. If available,
children received paediatric versions
6. Patient satisfaction in the intervention group as assessed by a questionnaire based on
the satisfaction questionnaire developed by Finkelstein et al
7. Cost effectiveness from the society perspective: cost in Euros per QALY gained
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “randomization took place on patient level
after stratification by age (ages 7-18 vs 18
years and older) as regular care differs be-
tween these age groups. The asthma nurse
used a list of random numbers to allocate
the patients to one of the two treatment
arms”
Allocation concealment (selection bias) Unclear risk Insufficient information
Blinding (performance bias and detection
bias)
All outcomes
High risk Participants could not be blinded, the nurse
practitioner was not blinded to the allo-
cation of the participants as they received
monthly transfers of the monitor data, and
there was no evidence of outcome assessor
blinding
Incomplete outcome data (attrition bias)
All outcomes
High risk 109 patients were randomised, 5 were lost
to follow up. There were technical prob-
lems andwhere data transfer wasmissed the
nurse practitioner attempted to contact the
patients by telephone however this was not
possible in 21% of missed data transfers. At
baseline there was 100% compliance with
filling in the questionnaires, for subsequent
measurements response rate was 85% to
92% for questionnaires and 81% to 90%
for diaries
28% of PEF data transfers from adults and
18% from children were missed
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Selective reporting (reporting bias) Low risk No apparent selective reporting
Other bias High risk Smoking was not taken account of, nei-
ther was the sex imbalance among the chil-
dren. The nurse practitioner could only be
reached during working hours
ACQ = Asthma Control Questionnaire
AQLQ = Asthma Quality of Life Questionnaire
ATAQ = Asthma Therapy Assessment Questionnaire
COPD = chronic obstructive pulmonary disease
FEV1 = forced expiratory volume in 1 second
MDI = metered dose inhaler
PEF = peak expiratory flow
PEFM = peak expiratory flow meter
PEFR = peak expiratory flow rate
SMS = Short Message Service (text)
RAST = radioallergosorbent test
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Bergman 2008 Prospective cohort study
Boone 2002 Intervention is purely educational with no feedback from a healthcare professional
Burkhart 1996 Trial of educational technique not telehealthcare as defined
Burkhart 2007 No feedback given to the patients who improve their self-monitoring
Chan 2003 Only 10 patients, non-randomised pilot study
Chandler 1990 RCT but only 3 asthma patients - therefore sample size is too small, pilot trial
Delaronde 2005 Not randomised - patient choice of intervention
Finkelstein 1998 Not RCT, pilot study only
Finkelstein 2000 Not RCT, discussion piece
Finkelstein 2001 Not RCT
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Finkelstein 2007 Not RCT
Huss 1992 Education only, not telehealthcare
Huss 2003 Education only, not telehealthcare
Jaana 2009 Systematic review
Joseph 2007 Programme delivered to African-American high school students at school with supervision, not telehealthcare
Joshi 2009 Prospective, non-randomised pre-post study
Karp 2000 Not limited to asthma; asthma data can not be separated.
Le 2007 Education only; not telehealthcare
Lin 2009 Convenience sampling method
Maiolo 2003 Before and after study design
Malone 2004 Same study as Chan 2007
Marcin 2004 Convenience sampling of children
McCLure 2008 Focus is on data collection methods not telehealthcare
Patel 2009 No medical advice given over telephone - therefore not telehealthcare
Pinnock 2007b Qualitative study
Porter 2006 Not telehealthcare; takes place in emergency health department
Reddel 1998 Study aims to assess only the quality of the spirometry
Smith 2009 Discussion article
Sockrider 2006 RCT of telehealthcare but protocol was to report after 12 months and only interim results from 9 months have
been published
van den Berg 2002 The phone line was for GPs to contact hospital for information regarding asthma guidelines
Wise 2007 No results; describes the system for obtaining them
Young 2003 Not asthma; range of other conditions
Zamith 2009 Not randomised
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RCT = randomised controlled trial
Characteristics of ongoing studies [ordered by study ID]
ACTRN12606000400561
Trial name or title Improving childhood asthma management through a telemedicine monitoring network
Methods A pilot formal randomised control trial
Participants 120 children with asthma who have had at least one admission to hospital or one emergency department or
paediatric or GP visit for asthma requiring steroid rescue within the previous 12 months. SMS patients must
have a mobile phone. Participants will be identified by discharge reports from participating hospitals. Age 3
to 16
Interventions There will be 3 groups of patients: a) regular care - GP/paediatrician/hospital emergency services, b)
telemedicine - twice a week automated telephone calls to the family, c) nurse support - telephone call by an
asthma nurse every 2 weeks. SMS Monitoring will also be undertaken, 40 adolescents with asthma will be
randomised to monitoring via mobile phone using SMS and a control group receives regular care
Outcomes Health resource utilisation over 6 months, health economic assessment over a 6-month period, school days
missed for children and days off work for parents, medication use and health-related quality of life
Starting date 11 September 2006
Contact information Mary Jackson, Department of Respiratory Medicine, Royal Children’s Hospital, Herston Rd, Herston, Bris-
bane, QLD, Australia Mary Jackson@health.qld.gov.au
Notes -
Apter NCT00115323
Trial name or title Comparison of two medication adherence strategies to improve asthma treatment adherence
Methods Treatment, randomised, open-label, parallel-assignment, efficacy study
Participants Recruitment will be from practices serving low-income and minority individuals. Age 18 to 90 and receiving
treatment for asthma at one of the participating clinics, current use of prescribed inhaled corticosteroids,
evidence of reversible airflow obstruction as follows: FEV1 less than 80% at the time of study entry or within
3 years prior to study entry. An increase of greater than 15% and 200ml in FEV1 with asthma treatment over
the last 3 years or evidence of reversible airflow obstruction on administration of albuterol
Interventions Comparison of a problem-solving intervention with an attention control intervention to improve and sustain
asthma self management in a clinical setting. There will be strategies to address contextual factors related to
adherence
Outcomes Adherence to prescribed inhaled steroid regimen measured at week 26, FEV1 and quality of life factors
Starting date May 2005
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Contact information Apter, University of Pennsylvania, Philadelphia, Pennsylvania 19104
Notes This study does not appear to have a proper control arm and as such would not be eligible to be included in
the systematic review and meta-analysis
Bendeer NCT00958932
Trial name or title Telecommunication Enhanced Asthma Management TEAM
Methods Treatment randomised, single-blind (investigator), placebo control, parallel assignment
Participants 1000 parents of 3 to 12-year old children in Colorado who require daily corticosteroid inhaler
Interventions Speech recognition calls are tailored to specific situations, e.g. new or re-issued corticosteroids. Filling an
initial or an active prescription. Follow up after an asthma exacerbation. Moderate exercise
Outcomes medication adherence and urgent care visits
Starting date Sept 2009
Contact information Bruce Bendeer, National Jewish Health, Denver, Colorado, USA, 80206
Notes -
Clover N0702196597
Trial name or title Self-management of chronic conditions using telemedicine
Methods Immediate transfer of peak flow from a mobile phone to a remote server with monitoring software, i.e.
distribution of most recent readings or trend analysis is calculated and fed back to mobile phone
Participants -
Interventions -
Outcomes -
Starting date -
Contact information Tim Clover, T+ Medical Ltd, The Magdalen Centre, Oxford Science Park, Oxford, OX4 4GA
Notes Health Technology Devices Programme HTD 244
63Telehealthcare for asthma (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Finkelstein CRISP
Trial name or title Inhaled steroid adherence in moderate and severe asthma
Methods The Internet-based Home Asthma Telemonitoring (HAT) system, designed to give continuous individualised
help to asthma patients following their self-care plans and to notify their healthcare providers of changes.
Patients will take their PEF daily and answer symptom questions on asthma status and an asthma nurse case
manager will find out if patients are not following self-care plans and if there are any clinically significant
conditions. She can then contact the patient and give advice about dealing with an exacerbation
Participants 240 inner-city adult asthma patients for 12 months
Interventions Home asthma telehealthcare is designed to provide continuous tailored help to asthma patients
Outcomes Clinical outcomes as measured by electronic peak flow, adherence to self-care
Starting date 2005
Contact information Finkelstein
Notes -
Friedman CRISP
Trial name or title Impact of a telecommunication system in childhood asthma
Methods Telephone Linked Communications for Asthma is a computer-based telecommunications system than moni-
tors educates and counsels asthmatic children and their parents through regular automated conversations and
reports finding to primary care
Participants Children aged 5 to 16 with mild to moderate asthma
Interventions A computer-based telecommunication system is used to help parents and children keep their asthma under
control. It converses with parents and children weekly at home. It provides education and counselling appro-
priate to the self-monitoring and medication use of the child. This information is stored in a database and
passed on to the primary care provider
Outcomes Changes inPEF, quality of life and lung function and social outcomes including the impact of the child’s asthma
on the family. Health services outcomes include utilisation of urgent care services and unscheduled office
visits. Attitudes of children, parents and providers analysed using qualitative and quantitative questioning
Starting date 1999
Contact information Friedman
Notes -
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Garbutt NCT 00860834
Trial name or title Parents, pediatricians and asthma telephone coaches partner to improve control of asthma in children (The
PARTNER Study)
Methods Randomised, single-blind with active control, parallel-assignment, efficacy study
Participants 1000 children aged 5 to 12 years old their parents and their community paediatricians
Interventions Asthma education will be given to community paediatricians and then an asthma coach will phone parents
of children who have asthma to support and give active support to achieving asthma goals with partnership
from the community paediatrician
Outcomes Asthma control, asthma-related quality of life, urgent care events, adherence to guideline recommended
asthma maintenance care behaviours, cost-effectiveness
Starting date August 2008
Contact information Jane Garbutt and Robert Srunk, Washington University School of Medicine, St Louis, Missouri, USA 63110
Notes This is a larger more general population than in the other Garbutt study
Garbutt NCT00660322
Trial name or title Using the telephone to improve care in childhood asthma
Methods 12-month randomised controlled trial
Participants 362 children aged 5 to 12 under care of community paediatricians
Interventions A series of brief telephone calls with a trained coach to help the parent manage the child’s asthma care. The
coach teaches self-management skills, helps the parent with asthma medications, supports the parent and
provides reminders for outpatient appointments
Outcomes Parental asthma related quality of life and urgent care events for asthma over one year
Starting date Jan 2004
Contact information Jane Garbutt, Washington University School of Medicine
Notes This is a low-income, urban neighbourhood
Gustafson NCT00214383
Trial name or title Internet Telehealth for Pediatric Asthma Case Management CHESS
Methods Randomised controlled intervention trial, 12 months
Participants Parents of children age 4 to 12 with asthma
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Gustafson NCT00214383 (Continued)
Interventions Internet telehealth - CHESS with nurse case management
Outcomes Improve adherence to controller medications
Improve asthma control and reduce health care utilisation
Starting date May 2004
Contact information Gustafson, University of Wisconsin
Notes -
Gustafson NCT00993590
Trial name or title Mobile CHESS Research on Emergency Medical Services for Children
Methods Supportive care, randomised, open-label, placebo control, parallel-assignment, efficacy study
Participants 400 low-income teenagers with asthma-related emergency care or asthma hospitalisation in the last 12months.
They also receive medical care from the managed care organisations participating in the study
Interventions This group will receive a smart phone with the ability to contact their case managers and primary provider,
to communicate with the managed care organisation case managers, their peers, share information regarding
health status, receive reminders to take medications and set up follow up. To receive feedback and tailored
advice on their asthma plan and the use of asthma resources. And also give access to asthma educational
materials and provide monthly study outcome data monthly for 12 months
Outcomes Asthma control test scores over 12 months, asthma-related healthcare utilisation and school absenteeism
Starting date June 2008
Contact information Gustafson, Centre for Health Enhancement Systems Studies (CHESS), Milwaukee, Wisconsin, USA 53214
Notes -
Mayers NCT00562081
Trial name or title The Virtual Asthma Clinic
Methods Phase IV, prevention, randomised, single-blind (subject), placebo control, parallel-assignment efficacy study
over 12 months
Participants Physician diagnosis of asthma, FEV1 of at least 50% of predicted at baseline, evidence of 12% increase in
FEV1 following inhaled bronchodilator. Ages 18 to 70
Interventions Standardised education to all participants, baseline pulmonary function tests and instructions on using a peak
flow monitor. One arm will receive active therapy using the internet site or a placebo therapy using a web-
based intervention. The active website will monitor the intervention group participants’ asthma profile daily,
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Mayers NCT00562081 (Continued)
with access to a certified asthma educator. IF patients do not log on for 7 days with poor control or 14 days
with good control they will receive a telephone call
Outcomes The 15 D and AQLQ at baseline, 6 months and 12 months, spirometry at 12 months. Symptom surveys at
log in by the intervention groups
Starting date March 2005
Contact information Mayers, University of Alberta Hospital, Edmonton, Alberta, Canada, T6G 2B7
Notes 15 D and AQLQ are questionnaires
Moldrup NCT00917410
Trial name or title Mobile phone text for optimising asthma treatment
Methods Supportive care, randomised, open-label, placebo control, single group assignment
Participants Adults with asthma age 18 to 45
Interventions The SMS (text) tool on mobile phones can be used to monitor asthma. Sequences of SMS messages were
sent to the intervention group. They contained monitoring questions and a reminder to take preventive
medication
Outcomes Asthma control test, EQ-5D, use of health services and used of preventive medicine
Starting date November 2007
Contact information Moldrup, University of Copenhagen, Copenhagen, Denmark 2100
Notes This study is noted as having been suspended
NCT00149474
Trial name or title Peak flow monitoring in older adults with asthma
Methods 5 year demonstration and education project, randomised
Participants 260 adults aged 50 or older with asthma, using asthma medications, with a greater than 12% increase in
FEV1 after 2 puffs of inhaled beta agonist
Interventions Assessment of the value of peak flow monitoring over symptoms monitoring in this age group. And compare
3 parallel asthma education programmes for older adults
Outcomes Frequency and cost of health care utilisation for asthma and asthma-specific quality of life
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NCT00149474 (Continued)
Starting date August 1994
Contact information No contact information provided, performed in Portland
Notes This study has apparently been completed
Osman N0411013273
Trial name or title A randomised controlled trial of benefits of specialist review or telephone follow up after an Accident and
Emergency attendance for asthma
Methods Randomised controlled study of the benefits of follow up
Participants 300 patients recruited from A&E at Aberdeen Royal Infirmary
Interventions Control group receive normal present care, group A out-patient clinic review, group B telephone follow up
with mailed information group D out-patient clinic review and telephone follow up with mailed information
Outcomes A&E attendance, GP attendance, medication, symptoms and quality of life
Starting date 1 October 1997
Contact information Liesl Osman, University of Aberdeen, med078@abdn.ac.uk
Notes -
Partridge N0016132017
Trial name or title Proposal to study whether we can reduce hospital attendance by those with respiratory conditions without
compromising care by the use of telephone consultation
Methods Replacement of traditional face-to-face consultations with telephone consultations
Participants 100 patients taken from the lung disease and asthma clinics
Interventions Telephone consultations
Outcomes Patient satisfaction, number of those telephoned needing face-to-face follow up. Costs of face-to-face consul-
tation, disease profile of 2 study arms
Starting date 13 August 2003
Contact information ProfMartynRPartridge, RespiratoryMedicine,NHLI,CharingCrossHospital, FulhamPalaceRoad, London
m.r.partridge@imperial.ac.uk
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Partridge N0016132017 (Continued)
Notes -
Perry NCT00964301
Trial name or title Telemedicine education for rural children with asthma
Methods Treatment non-randomised, parallel assignment efficacy study
Participants Low-income minority children,age 7 to 17, with asthma in the Delta region of Arkansas
Interventions Interactive school-based telemedicine program, education delivered via teleconference at school. Monthly
sessions for a year
Outcomes Asthma symptoms control, activity level, family/child emotional health, asthma knowledge, self-efficacy and
quality of life in intervention participants and their caregivers
Starting date August 2009
Contact information Perry T, Arkansas Children’s Hospital Research Institute, perrytamarat@uams.edu
Notes -
Ricci 2001 In progress
Trial name or title A telehealthcare system for home monitoring of respiratory function in children affected by bronchial asthma
Methods Controlled randomised trial
Participants Participants from a family paediatrician and a paediatric allergist recruited over a 24 month period in Pavia,
Italy. 20 patients in each arm ages 10 to 16
Interventions Intervention group performed daily spirometry and a daily symptom diary via the telephone
Outcomes Resuscitation of patients with asthma, medical intervention - re-hospitalisation or emergency dept visit, cost,
quality of life of patients and of their families, therapeutic schemes
Starting date 2001
Contact information A. Ricci, Dipartimento di Scienze Pediatriche, Universita degli Studi, Pavia
Notes Study has published its methodology
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Ryan NCT 00512837
Trial name or title Mobile phone based structured intervention, the CYMPLA trial
Methods Supportive care, randomised, single-blind (investigator), active control, parallel assignment
Participants 312 12 years and older patients with poorly controlled asthma who speak English and have a mobile phone
Interventions Patients in the mobile phone group will monitor their asthma daily using their mobile phone to record
symptoms medication and lung function. They will receive instantaneous feedback to their phone providing
a visual indication of asthma control and prompts about therapy. They will have web-based access with their
clinician to all readings. An asthma nurse will guide them using BTS in order to gain control
Outcomes Change in asthma control between baseline and 6 months as measured by Asthma Control Questionnaire
24. The ACQ measures 0 good control to 6. Secondary outcome measures - mean difference in ACQ at 3,
6, 24 and 36 months. Mean difference in mini asthma-related quality of life questionnaire
Starting date November 2007
Contact information Dermot Ryan, University of Aberdeen, dermotryan@doctors.org.uk
Notes Data undergoing statistics processing
Sparrow NCT00232557
Trial name or title Telecommunications system in asthma
Methods Randomised, open-label, active control, parallel-assignment, efficacy study
Participants Adults with asthma receiving treatment with one or more daily controller medications. With FEV1 bron-
chodilator response of at least 12%
Interventions Telephone linked communications systems will be used to provide education, behavioural counselling and
monitoring of clinical status
Outcomes Medication adherence, quality of life, utilisation of urgent care services, oral corticosteroid use
Starting date August 2004
Contact information Sparrow, Dept of Veterans Affairs, VA Boston HealthCare System, Boston, Massachusetts, United States
02130
Notes Study scheduled to finish in December 2009
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Strunk NCT00910585
Trial name or title Coaching in childhood asthma
Methods Prevention, randomised, open-label, active control, parallel-assignment, efficacy study
Participants Mothers of 191 Afro-American children with asthma aged 2 to 8, hospitalised for an acute exacerbation and
with Medicaid insurance
Interventions Coaching in person and via telephone to provide behavioural and social support
Outcomes Rehospitalisation over next 2 years
Starting date January 1997
Contact information Strunk, Washington University School of Medicine, St Louis, Missouri, USA, 63110
Notes -
Vollmer NCT 00414817
Trial name or title Telephone-based program to promote inhaled corticosteroid adherence among individuals with asthma
Methods Supportive care, randomised, open-label, active control (usual care), parallel-assignment efficacy study over a
19-month period
Participants 14,064 participants with asthma over the age of 18
Interventions A telephone-based intervention which uses interactive voice recognition technology to remind people with
asthma to take their medication and order refills when appropriate. The technology also gives recorded asthma
education and can transfer participants to a pharmacist to arrange a prescription. Participants will receive
between 1 and 8 phone calls during the study
Outcomes Approximately 2000 participants will be sent a questionnaire at the study entry and again at the end of the
study to assess quality of life, respiratory health, asthma control, depression, inhaler use beliefs and satisfaction
with the intervention. Electronic medical record data will be used to help determine adherence rates
Starting date June 2007
Contact information Vollmer, Kaiser Permanente NW, Centre for Health Research, KPNW, Portland, Oregon United States
Notes -
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Wouters NCT 00411346
Trial name or title Patient Research In Self-Management of Asthma (PRISMA)
Methods Randomised controlled trial comparing a nurse-led telemonitoring programme versus regular care in asthmatic
outpatients
Participants 7 years or older, asthma severity of stage I to III as described by GINA, competent to use an asthma monitor
and possessing a household phone connection
Interventions Lung function tests including PEF is recorded into an electronic monitor and transfers the data to a central
database so that a nurse using protocols can supervised the disease status of patients and manage their
medication accordingly
Outcomes Asthma-specific quality of life at 1 year, asthma symptoms at 1 year, generic quality of life at 1 year, direct
and indirect costs during 1 year, satisfaction and feasibility at 1 year
Starting date January 2003
Contact information Emiel Wouters, Dept of Respiratory Medicine, University Hospital Maastricht, Limburg, Netherlands 6202
AZ
Notes The study is finished but no publications are yet listed
A&E = Accident and Emergency department
ACQ = Asthma Control Questionnaire
AQLQ = Asthma Quality of Life Questionnaire
FEV1 = forced expiratory volume in 1 second
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D A T A A N D A N A L Y S E S
Comparison 1. Asthma quality of life questionnaires
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 AQLQ Juniper mean scores 9 3119 Mean Difference (IV, Fixed, 95% CI) 0.08 [0.01, 0.16]
2 Sensitivity analysis AQLQ
studies judged low risk of bias
8 2151 Mean Difference (IV, Fixed, 95% CI) 0.08 [-0.00, 0.16]
3 Subgroup telephone only AQLQ
scores
5 2556 Mean Difference (IV, Fixed, 95% CI) 0.04 [-0.05, 0.12]
4 Subgroup AQLQ recruited in
secondary care
3 380 Mean Difference (IV, Fixed, 95% CI) 0.11 [-0.08, 0.30]
5 Subgroup AQLQ recruited in
primary care
5 2131 Mean Difference (IV, Fixed, 95% CI) 0.11 [0.02, 0.21]
Comparison 2. One or more emergency department visit; no. of patients with events
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Emergency department visit in 3
months
1 122 Odds Ratio (M-H, Fixed, 95% CI) 0.48 [0.16, 1.39]
2 Emergency department visit in
12 months
5 619 Odds Ratio (M-H, Fixed, 95% CI) 1.16 [0.52, 2.58]
3 Subgroup secondary care
populations
2 137 Odds Ratio (M-H, Fixed, 95% CI) 1.45 [0.41, 5.09]
4 Subgroup primary care
populations
1 253 Odds Ratio (M-H, Fixed, 95% CI) 4.02 [0.36, 45.02]
Comparison 3. One or more hospitalisation events; no. of patients with events
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 One or more hospitalisation
event in 3 months of study
2 138 Odds Ratio (M-H, Random, 95% CI) 0.47 [0.01, 36.46]
2 One or more hospitalisation
event in 12 months of study
4 499 Odds Ratio (M-H, Fixed, 95% CI) 0.21 [0.07, 0.61]
3 Subgroup - secondary care; no.
of patients with one or more
hospitalisations in 12 months
2 126 Odds Ratio (M-H, Fixed, 95% CI) 0.14 [0.04, 0.49]
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4 Subgroup - primary care; no.
of patients with one or more
hospitalisations in 12 months
1 134 Odds Ratio (M-H, Fixed, 95% CI) 3.05 [0.12, 76.10]
5 No. of patients with one or
more hospitalisation events in
12 months excluding Kokubu
study
3 433 Odds Ratio (M-H, Fixed, 95% CI) 0.30 [0.07, 1.25]
Analysis 1.1. Comparison 1 Asthma quality of life questionnaires, Outcome 1 AQLQ Juniper mean scores.
Review: Telehealthcare for asthma
Comparison: 1 Asthma quality of life questionnaires
Outcome: 1 AQLQ Juniper mean scores
Study or subgroup Experimental Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Chan 2007 60 6.1 (1.1) 60 5.8 (1.2) 3.1 % 0.30 [ -0.11, 0.71 ]
Clark 2007 311 2.1 (0.9) 297 2.1 (0.9) 25.6 % 0.0 [ -0.14, 0.14 ]
de Jongste 2009 77 6.2 (0.8) 74 6.2 (0.7) 9.1 % 0.0 [ -0.24, 0.24 ]
Gruffydd-Jones 2005 84 5.93 (1.64) 62 5.79 (0.9) 3.0 % 0.14 [ -0.28, 0.56 ]
Pinnock 2003 137 5.15 (1.28) 141 5.22 (1.14) 6.5 % -0.07 [ -0.36, 0.22 ]
Pinnock 2007 270 5.29 (1.21) 286 5.27 (1.16) 13.5 % 0.02 [ -0.18, 0.22 ]
Van der Meer 2009 91 6.29 (0.68) 92 5.97 (0.69) 13.3 % 0.32 [ 0.12, 0.52 ]
Vollmer 2006 481 5.2 (1.2) 487 5.1 (1.2) 23.0 % 0.10 [ -0.05, 0.25 ]
Willems 2008 55 5.73 (1.09) 54 5.48 (1.18) 2.9 % 0.25 [ -0.18, 0.68 ]
Total (95% CI) 1566 1553 100.0 % 0.08 [ 0.01, 0.16 ]
Heterogeneity: Chi2 = 10.50, df = 8 (P = 0.23); I2 =24%
Test for overall effect: Z = 2.29 (P = 0.022)
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
Favours control Favours experimental
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Analysis 1.2. Comparison 1 Asthma quality of life questionnaires, Outcome 2 Sensitivity analysis AQLQ
studies judged low risk of bias.
Review: Telehealthcare for asthma
Comparison: 1 Asthma quality of life questionnaires
Outcome: 2 Sensitivity analysis AQLQ studies judged low risk of bias
Study or subgroup Experimental Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Chan 2007 60 6.1 (1.1) 60 5.8 (1.2) 4.0 % 0.30 [ -0.11, 0.71 ]
Clark 2007 311 2.1 (0.9) 297 2.1 (0.9) 33.3 % 0.0 [ -0.14, 0.14 ]
de Jongste 2009 77 6.2 (0.8) 74 6.2 (0.7) 11.9 % 0.0 [ -0.24, 0.24 ]
Gruffydd-Jones 2005 84 5.93 (1.64) 62 5.79 (0.9) 3.9 % 0.14 [ -0.28, 0.56 ]
Pinnock 2003 137 5.15 (1.28) 141 5.22 (1.14) 8.4 % -0.07 [ -0.36, 0.22 ]
Pinnock 2007 270 5.29 (1.21) 286 5.27 (1.16) 17.5 % 0.02 [ -0.18, 0.22 ]
Van der Meer 2009 91 6.29 (0.68) 92 5.97 (0.69) 17.3 % 0.32 [ 0.12, 0.52 ]
Willems 2008 55 5.73 (1.09) 54 5.48 (1.18) 3.7 % 0.25 [ -0.18, 0.68 ]
Total (95% CI) 1085 1066 100.0 % 0.08 [ 0.00, 0.16 ]
Heterogeneity: Chi2 = 10.45, df = 7 (P = 0.16); I2 =33%
Test for overall effect: Z = 1.90 (P = 0.058)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours experimental Favours control
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Analysis 1.3. Comparison 1 Asthma quality of life questionnaires, Outcome 3 Subgroup telephone only
AQLQ scores.
Review: Telehealthcare for asthma
Comparison: 1 Asthma quality of life questionnaires
Outcome: 3 Subgroup telephone only AQLQ scores
Study or subgroup Experimental Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Clark 2007 311 2.1 (0.9) 297 2.1 (0.9) 35.8 % 0.0 [ -0.14, 0.14 ]
Gruffydd-Jones 2005 84 5.93 (1.64) 62 5.79 (0.9) 4.2 % 0.14 [ -0.28, 0.56 ]
Pinnock 2003 137 5.15 (1.28) 141 5.22 (1.14) 9.0 % -0.07 [ -0.36, 0.22 ]
Pinnock 2007 270 5.29 (1.21) 286 5.27 (1.16) 18.9 % 0.02 [ -0.18, 0.22 ]
Vollmer 2006 481 5.2 (1.2) 487 5.1 (1.2) 32.1 % 0.10 [ -0.05, 0.25 ]
Total (95% CI) 1283 1273 100.0 % 0.04 [ -0.05, 0.12 ]
Heterogeneity: Chi2 = 1.73, df = 4 (P = 0.79); I2 =0.0%
Test for overall effect: Z = 0.81 (P = 0.42)
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
Favours experimental Favours control
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Analysis 1.4. Comparison 1 Asthma quality of life questionnaires, Outcome 4 Subgroup AQLQ recruited in
secondary care.
Review: Telehealthcare for asthma
Comparison: 1 Asthma quality of life questionnaires
Outcome: 4 Subgroup AQLQ recruited in secondary care
Study or subgroup Experimental Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Chan 2007 60 6.1 (1.1) 60 5.8 (1.2) 20.5 % 0.30 [ -0.11, 0.71 ]
de Jongste 2009 77 6.2 (0.8) 74 6.2 (0.7) 60.5 % 0.0 [ -0.24, 0.24 ]
Willems 2008 55 5.73 (1.09) 54 5.48 (1.18) 19.1 % 0.25 [ -0.18, 0.68 ]
Total (95% CI) 192 188 100.0 % 0.11 [ -0.08, 0.30 ]
Heterogeneity: Chi2 = 2.04, df = 2 (P = 0.36); I2 =2%
Test for overall effect: Z = 1.15 (P = 0.25)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours experimental Favours control
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Analysis 1.5. Comparison 1 Asthma quality of life questionnaires, Outcome 5 Subgroup AQLQ recruited in
primary care.
Review: Telehealthcare for asthma
Comparison: 1 Asthma quality of life questionnaires
Outcome: 5 Subgroup AQLQ recruited in primary care
Study or subgroup Experimental Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Gruffydd-Jones 2005 84 5.93 (1.64) 62 5.79 (0.9) 5.1 % 0.14 [ -0.28, 0.56 ]
Pinnock 2003 137 5.15 (1.28) 141 5.22 (1.14) 10.9 % -0.07 [ -0.36, 0.22 ]
Pinnock 2007 270 5.29 (1.21) 286 5.27 (1.16) 22.8 % 0.02 [ -0.18, 0.22 ]
Van der Meer 2009 91 6.29 (0.68) 92 5.97 (0.69) 22.5 % 0.32 [ 0.12, 0.52 ]
Vollmer 2006 481 5.2 (1.2) 487 5.1 (1.2) 38.7 % 0.10 [ -0.05, 0.25 ]
Total (95% CI) 1063 1068 100.0 % 0.11 [ 0.02, 0.21 ]
Heterogeneity: Chi2 = 6.66, df = 4 (P = 0.16); I2 =40%
Test for overall effect: Z = 2.39 (P = 0.017)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours experimental Favours control
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Analysis 2.1. Comparison 2 One or more emergency department visit; no. of patients with events,
Outcome 1 Emergency department visit in 3 months.
Review: Telehealthcare for asthma
Comparison: 2 One or more emergency department visit; no. of patients with events
Outcome: 1 Emergency department visit in 3 months
Study or subgroup Intervention Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Guendelman 2002 6/62 11/60 100.0 % 0.48 [ 0.16, 1.39 ]
Total (95% CI) 62 60 100.0 % 0.48 [ 0.16, 1.39 ]
Total events: 6 (Intervention), 11 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.36 (P = 0.17)
Test for subgroup differences: Not applicable
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Analysis 2.2. Comparison 2 One or more emergency department visit; no. of patients with events,
Outcome 2 Emergency department visit in 12 months.
Review: Telehealthcare for asthma
Comparison: 2 One or more emergency department visit; no. of patients with events
Outcome: 2 Emergency department visit in 12 months
Study or subgroup Intervention Control Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Chan 2007 4/60 2/60 2.07 [ 0.36, 11.76 ]
Donald 2008a 7/36 5/35 1.45 [ 0.41, 5.09 ]
Kokubu 2000 32/32 34/34 0.0 [ 0.0, 0.0 ]
Rasmussen 2005 2/85 1/168 4.02 [ 0.36, 45.02 ]
Willems 2008 0/55 4/54 0.10 [ 0.01, 1.92 ]
Total (95% CI) 268 351 1.16 [ 0.52, 2.58 ]
Total events: 45 (Intervention), 46 (Control)
Heterogeneity: Chi2 = 4.20, df = 3 (P = 0.24); I2 =29%
Test for overall effect: Z = 0.36 (P = 0.72)
Test for subgroup differences: Not applicable
0.005 0.1 1 10 200
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Analysis 2.3. Comparison 2 One or more emergency department visit; no. of patients with events,
Outcome 3 Subgroup secondary care populations.
Review: Telehealthcare for asthma
Comparison: 2 One or more emergency department visit; no. of patients with events
Outcome: 3 Subgroup secondary care populations
Study or subgroup Intervention Control Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Donald 2008a 7/36 5/35 1.45 [ 0.41, 5.09 ]
Kokubu 2000 32/32 34/34 0.0 [ 0.0, 0.0 ]
Total (95% CI) 68 69 1.45 [ 0.41, 5.09 ]
Total events: 39 (Intervention), 39 (Control)
Heterogeneity: Chi2 = 0.0, df = 0 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 0.58 (P = 0.56)
Test for subgroup differences: Not applicable
0.02 0.1 1 10 50
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Analysis 2.4. Comparison 2 One or more emergency department visit; no. of patients with events,
Outcome 4 Subgroup primary care populations.
Review: Telehealthcare for asthma
Comparison: 2 One or more emergency department visit; no. of patients with events
Outcome: 4 Subgroup primary care populations
Study or subgroup Intervention Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Rasmussen 2005 2/85 1/168 100.0 % 4.02 [ 0.36, 45.02 ]
Total (95% CI) 85 168 100.0 % 4.02 [ 0.36, 45.02 ]
Total events: 2 (Intervention), 1 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.13 (P = 0.26)
Test for subgroup differences: Not applicable
0.005 0.1 1 10 200
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Analysis 3.1. Comparison 3 One or more hospitalisation events; no. of patients with events, Outcome 1
One or more hospitalisation event in 3 months of study.
Review: Telehealthcare for asthma
Comparison: 3 One or more hospitalisation events; no. of patients with events
Outcome: 1 One or more hospitalisation event in 3 months of study
Study or subgroup Intervention Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Guendelman 2002 4/62 1/60 51.3 % 4.07 [ 0.44, 37.50 ]
Ostojic 2005 2/8 7/8 48.7 % 0.05 [ 0.00, 0.66 ]
Total (95% CI) 70 68 100.0 % 0.47 [ 0.01, 36.46 ]
Total events: 6 (Intervention), 8 (Control)
Heterogeneity: Tau2 = 8.35; Chi2 = 6.40, df = 1 (P = 0.01); I2 =84%
Test for overall effect: Z = 0.34 (P = 0.73)
Test for subgroup differences: Not applicable
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Analysis 3.2. Comparison 3 One or more hospitalisation events; no. of patients with events, Outcome 2
One or more hospitalisation event in 12 months of study.
Review: Telehealthcare for asthma
Comparison: 3 One or more hospitalisation events; no. of patients with events
Outcome: 2 One or more hospitalisation event in 12 months of study
Study or subgroup Intervention Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Chan 2007 1/60 1/60 5.5 % 1.00 [ 0.06, 16.37 ]
Donald 2008a 1/31 6/29 33.4 % 0.13 [ 0.01, 1.14 ]
Kokubu 2000 2/32 11/34 55.6 % 0.14 [ 0.03, 0.69 ]
Rasmussen 2005 0/85 1/168 5.6 % 0.65 [ 0.03, 16.20 ]
Total (95% CI) 208 291 100.0 % 0.21 [ 0.07, 0.61 ]
Total events: 4 (Intervention), 19 (Control)
Heterogeneity: Chi2 = 2.12, df = 3 (P = 0.55); I2 =0.0%
Test for overall effect: Z = 2.88 (P = 0.0040)
Test for subgroup differences: Not applicable
0.002 0.1 1 10 500
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Analysis 3.3. Comparison 3 One or more hospitalisation events; no. of patients with events, Outcome 3
Subgroup - secondary care; no. of patients with one or more hospitalisations in 12 months.
Review: Telehealthcare for asthma
Comparison: 3 One or more hospitalisation events; no. of patients with events
Outcome: 3 Subgroup - secondary care; no. of patients with one or more hospitalisations in 12 months
Study or subgroup Intervention Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Donald 2008a 1/31 6/29 37.5 % 0.13 [ 0.01, 1.14 ]
Kokubu 2000 2/32 11/34 62.5 % 0.14 [ 0.03, 0.69 ]
Total (95% CI) 63 63 100.0 % 0.14 [ 0.04, 0.49 ]
Total events: 3 (Intervention), 17 (Control)
Heterogeneity: Chi2 = 0.00, df = 1 (P = 0.95); I2 =0.0%
Test for overall effect: Z = 3.04 (P = 0.0024)
Test for subgroup differences: Not applicable
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Analysis 3.4. Comparison 3 One or more hospitalisation events; no. of patients with events, Outcome 4
Subgroup - primary care; no. of patients with one or more hospitalisations in 12 months.
Review: Telehealthcare for asthma
Comparison: 3 One or more hospitalisation events; no. of patients with events
Outcome: 4 Subgroup - primary care; no. of patients with one or more hospitalisations in 12 months
Study or subgroup Intervention Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Rasmussen 2005 1/67 0/67 100.0 % 3.05 [ 0.12, 76.10 ]
Total (95% CI) 67 67 100.0 % 3.05 [ 0.12, 76.10 ]
Total events: 1 (Intervention), 0 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.68 (P = 0.50)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
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Analysis 3.5. Comparison 3 One or more hospitalisation events; no. of patients with events, Outcome 5 No.
of patients with one or more hospitalisation events in 12 months excluding Kokubu study.
Review: Telehealthcare for asthma
Comparison: 3 One or more hospitalisation events; no. of patients with events
Outcome: 5 No. of patients with one or more hospitalisation events in 12 months excluding Kokubu study
Study or subgroup Intervention Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Chan 2007 1/60 1/60 12.3 % 1.00 [ 0.06, 16.37 ]
Donald 2008a 1/31 6/29 75.1 % 0.13 [ 0.01, 1.14 ]
Rasmussen 2005 0/85 1/168 12.6 % 0.65 [ 0.03, 16.20 ]
Total (95% CI) 176 257 100.0 % 0.30 [ 0.07, 1.25 ]
Total events: 2 (Intervention), 8 (Control)
Heterogeneity: Chi2 = 1.52, df = 2 (P = 0.47); I2 =0.0%
Test for overall effect: Z = 1.65 (P = 0.099)
Test for subgroup differences: Not applicable
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Table 2. Included abstracts (Continued)
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